BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hsu SH, Wang B, Kota J, Yu J, Costinean S, Kutay H, Yu L, Bai S, La Perle K, Chivukula RR, Mao H, Wei M, Clark KR, Mendell JR, Caligiuri MA, Jacob ST, Mendell JT, Ghoshal K. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest. 2012;122:2871-2883. [PMID: 22820288 DOI: 10.1172/jci63539] [Cited by in Crossref: 583] [Cited by in F6Publishing: 603] [Article Influence: 53.0] [Reference Citation Analysis]
Number Citing Articles
1 Behrouj H, Moridi H, Moradi MN, Ghasemi H. miR-122 dysregulation is associated to the type2 diabetes mellitus-induced dyslipidemia and hyperglycemia independently to its variant rs17669.. [DOI: 10.21203/rs.3.rs-2416128/v1] [Reference Citation Analysis]
2 Abdel Halim AS, Rudayni HA, Chaudhary AA, Ali MAM. MicroRNAs: Small molecules with big impacts in liver injury. J Cell Physiol 2023;238:32-69. [PMID: 36317692 DOI: 10.1002/jcp.30908] [Reference Citation Analysis]
3 Lee KC, Wu PS, Lin HC. Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis. Clin Mol Hepatol 2023;29:77-98. [PMID: 36226471 DOI: 10.3350/cmh.2022.0237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yang Y, Lv Q, Huang X, Fan J, Li P, Zhu H, Kang P, Liu Y. Identification and characterization of MicroRNAs in pig liver after the LPS challenge using RNA-seq. Food and Agricultural Immunology 2022;33:652-63. [DOI: 10.1080/09540105.2022.2109602] [Reference Citation Analysis]
5 Wang J, Li G, Lin M, Lin S, Wu L. microRNA-338-3p suppresses lipopolysaccharide-induced inflammatory response in HK-2 cells. BMC Mol Cell Biol 2022;23:60. [PMID: 36564725 DOI: 10.1186/s12860-022-00455-0] [Reference Citation Analysis]
6 Warner JB, Guenthner SC, Hardesty JE, McClain CJ, Warner DR, Kirpich IA. Liver-specific drug delivery platforms: Applications for the treatment of alcohol-associated liver disease. World J Gastroenterol 2022; 28(36): 5280-5299 [DOI: 10.3748/wjg.v28.i36.5280] [Reference Citation Analysis]
7 Zaiou M. Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease. World J Gastroenterol 2022; 28(35): 5111-5128 [DOI: 10.3748/wjg.v28.i35.5111] [Reference Citation Analysis]
8 Panigrahi M, Palmer MA, Wilson JA. MicroRNA-122 Regulation of HCV Infections: Insights from Studies of miR-122-Independent Replication. Pathogens 2022;11:1005. [PMID: 36145436 DOI: 10.3390/pathogens11091005] [Reference Citation Analysis]
9 Roy N, Alencastro F, Roseman BA, Wilson SR, Delgado ER, May MC, Bhushan B, Bello FM, Jurczak MJ, Shiva S, Locker J, Gingras S, Duncan AW. Dysregulation of Lipid and Glucose Homeostasis in Hepatocyte-Specific SLC25A34 Knockout Mice. The American Journal of Pathology 2022;192:1259-1281. [DOI: 10.1016/j.ajpath.2022.06.002] [Reference Citation Analysis]
10 Hochreuter MY, Dall M, Treebak JT, Barrès R. MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives. Mol Metab 2022;:101581. [PMID: 36028120 DOI: 10.1016/j.molmet.2022.101581] [Reference Citation Analysis]
11 Duan Y, Gong K, Xu S, Zhang F, Meng X, Han J. Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics. Signal Transduct Target Ther 2022;7:265. [PMID: 35918332 DOI: 10.1038/s41392-022-01125-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Geng F, Yang F, Liu F, Zhao J, Zhang R, Hu S, Zhang J, Zhang X. A miR-137-XIAP axis contributes to the sensitivity of TRAIL-induced cell death in glioblastoma. Front Oncol 2022;12:870034. [DOI: 10.3389/fonc.2022.870034] [Reference Citation Analysis]
13 Liu S, Huang F, Ru G, Wang Y, Zhang B, Chen X, Chu L. Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application. Front Oncol 2022;12:902820. [DOI: 10.3389/fonc.2022.902820] [Reference Citation Analysis]
14 Malherbe DC, Messaoudi I. Transcriptional and Epigenetic Regulation of Monocyte and Macrophage Dysfunction by Chronic Alcohol Consumption. Front Immunol 2022;13:911951. [DOI: 10.3389/fimmu.2022.911951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Chun K. Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma. Pharmaceutics 2022;14:1380. [DOI: 10.3390/pharmaceutics14071380] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Li X, Zheng L, Zhang B, Deng Z, Luo T. The Structure Basis of Phytochemicals as Metabolic Signals for Combating Obesity. Front Nutr 2022;9:913883. [DOI: 10.3389/fnut.2022.913883] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Gao JR, Shi MM, Jiang H, Zhu XL, Wei LB, Qin XJ. MicroRNA-339-5p inhibits lipopolysaccharide-induced rat mesangial cells by regulating the Syk/Ras/c-Fos pathway. Naunyn Schmiedebergs Arch Pharmacol 2022. [PMID: 35687145 DOI: 10.1007/s00210-022-02261-z] [Reference Citation Analysis]
18 Wang Z, Tian Q, Tian Y, Zheng Z. MicroRNA-122-3p plays as the target of long non-coding RNA LINC00665 in repressing the progress of arthritis. Bioengineered 2022;13:13328-40. [DOI: 10.1080/21655979.2022.2081757] [Reference Citation Analysis]
19 Czaja AJ. Examining micro-ribonucleic acids as diagnostic and therapeutic prospects in autoimmune hepatitis. Expert Rev Clin Immunol 2022. [PMID: 35510750 DOI: 10.1080/1744666X.2022.2074839] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Khare S, Khare T, Ramanathan R, Ibdah JA. Hepatocellular Carcinoma: The Role of MicroRNAs. Biomolecules 2022;12:645. [DOI: 10.3390/biom12050645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Li J, Zhou J, Mu X, Shen S, Xu X, Luo Y, Luo Y, Ming Y, Wu Y, Peng Y. Regulation of XPO5 phosphorylation by PP2A in hepatocellular carcinoma. MedComm 2022;3. [DOI: 10.1002/mco2.125] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Simino LADP, Fontana MF, de Fante T, Panzarin C, Ignacio-souza LM, Milanski M, Torsoni MA, Desai M, Ross MG, Torsoni AS. Hepatic Epigenetic Reprogramming After Liver Resection in Offspring Alleviates the Effects of Maternal Obesity. Front Cell Dev Biol 2022;10:830009. [DOI: 10.3389/fcell.2022.830009] [Reference Citation Analysis]
23 Smith ES, Whitty E, Yoo B, Moore A, Sempere LF, Medarova Z. Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine. Cancers (Basel) 2022;14:1588. [PMID: 35326738 DOI: 10.3390/cancers14061588] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
24 Szczepanek J, Skorupa M, Tretyn A. MicroRNA as a Potential Therapeutic Molecule in Cancer. Cells 2022;11:1008. [PMID: 35326459 DOI: 10.3390/cells11061008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
25 Li S, Chen L. Exosomes in Pathogenesis, Diagnosis, and Treatment of Hepatocellular Carcinoma. Front Oncol 2022;12:793432. [PMID: 35155236 DOI: 10.3389/fonc.2022.793432] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Hu C, Li X, Sui Y, Chen Y, Zhao Y, Yang Y, Zhou Q, Ni H, Sun L, Gan W, Li J, Liu Y. Dicer deletion in hepatocytes promotes macrophages M1 polarization through dysregulated miR-192-3p/IGF2 in non-alcoholic steatohepatitis and hepatocellular carcinoma. Cancer Gene Ther 2022. [PMID: 35165388 DOI: 10.1038/s41417-022-00432-x] [Reference Citation Analysis]
27 Gaddam RR, Dhuri K, Kim YR, Jacobs JS, Kumar V, Li Q, Irani K, Bahal R, Vikram A. γ Peptide Nucleic Acid-Based miR-122 Inhibition Rescues Vascular Endothelial Dysfunction in Mice Fed a High-Fat Diet. J Med Chem 2022. [PMID: 35133835 DOI: 10.1021/acs.jmedchem.1c01831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Meumann N, Schmithals C, Elenschneider L, Hansen T, Balakrishnan A, Hu Q, Hook S, Schmitz J, Bräsen JH, Franke AC, Olarewaju O, Brandenberger C, Talbot SR, Fangmann J, Hacker UT, Odenthal M, Ott M, Piiper A, Büning H. Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors. Cancers (Basel) 2022;14:427. [PMID: 35053588 DOI: 10.3390/cancers14020427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Wang H, Hu Z, Sukumar UK, Bose RJ, Telichko A, Dahl JJ, Paulmurugan R. Ultrasound-Guided Microbubble-Mediated Locoregional Delivery of Multiple MicroRNAs Improves Chemotherapy in Hepatocellular Carcinoma. Nanotheranostics 2022;6:62-78. [PMID: 34976581 DOI: 10.7150/ntno.63320] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
30 Fornari F, Gramantieri L. Pathophysiology roles and translational opportunities of miRNAs in hepatocellular carcinoma. MicroRNA in Human Malignancies 2022. [DOI: 10.1016/b978-0-12-822287-4.00025-6] [Reference Citation Analysis]
31 Kim J, Yun YH, Jung Y. Therapeutic Potential of MicroRNAs and Their Nanoparticle-based Delivery in the Treatment of Liver Fibrosis. Biotechnologies for Gene Therapy 2022. [DOI: 10.1007/978-3-030-93333-3_1] [Reference Citation Analysis]
32 Pan X. Cholesterol Metabolism in Chronic Kidney Disease: Physiology, Pathologic Mechanisms, and Treatment. Sphingolipid Metabolism and Metabolic Disease 2022. [DOI: 10.1007/978-981-19-0394-6_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Miller M, Siddiqi SA. Recent perspectives on therapeutic significance of microRNAs in hepatocellular carcinoma. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3 2022. [DOI: 10.1016/b978-0-323-99283-1.00008-2] [Reference Citation Analysis]
34 Sanceau J, Gougelet A. Noncoding RNAs in liver cancer patients. Clinical Applications of Non-Coding RNAs in Cancer 2022. [DOI: 10.1016/b978-0-12-824550-7.00007-2] [Reference Citation Analysis]
35 Shankaraiah RC, Masatti L, Akanksha S, Negrini M. microRNAs and metabolism. MicroRNA in Human Malignancies 2022. [DOI: 10.1016/b978-0-12-822287-4.00006-2] [Reference Citation Analysis]
36 Marugame Y, Takeshita N, Yamada S, Yoshitomi R, Kumazoe M, Fujimura Y, Tachibana H. Sesame lignans upregulate glutathione S-transferase expression and downregulate microRNA-669c-3p. Bioscience of Microbiota, Food and Health 2022;41:66-72. [DOI: 10.12938/bmfh.2021-067] [Reference Citation Analysis]
37 Zhang Y, Tan YY, Chen PP, Xu H, Xie SJ, Xu SJ, Li B, Li JH, Liu S, Yang JH, Zhou H, Qu LH. Genome-wide identification of microRNA targets reveals positive regulation of the Hippo pathway by miR-122 during liver development. Cell Death Dis 2021;12:1161. [PMID: 34907157 DOI: 10.1038/s41419-021-04436-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Nazarie Ignat SR, Gharbia S, Hermenean A, Dinescu S, Costache M. Regenerative Potential of Mesenchymal Stem Cells' (MSCs) Secretome for Liver Fibrosis Therapies. Int J Mol Sci 2021;22:13292. [PMID: 34948088 DOI: 10.3390/ijms222413292] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
39 Meerson A, Khatib S, Mahajna J. Natural Products Targeting Cancer Stem Cells for Augmenting Cancer Therapeutics. Int J Mol Sci 2021;22:13044. [PMID: 34884848 DOI: 10.3390/ijms222313044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
40 Chang YM, Chen PC, Hsu CP, Ma PF, Chen HL, Hsu SH. Loss of hepatic miR-194 promotes liver regeneration and protects from acetaminophen-induced acute liver injury. Biochem Pharmacol 2022;195:114862. [PMID: 34843716 DOI: 10.1016/j.bcp.2021.114862] [Reference Citation Analysis]
41 Zeng X, Li Z, Zhu C, Xu L, Sun Y, Han S. Research progress of nanocarriers for gene therapy targeting abnormal glucose and lipid metabolism in tumors. Drug Deliv 2021;28:2329-47. [PMID: 34730054 DOI: 10.1080/10717544.2021.1995081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
42 Juaid N, Amin A, Abdalla A, Reese K, Alamri Z, Moulay M, Abdu S, Miled N. Anti-Hepatocellular Carcinoma Biomolecules: Molecular Targets Insights. Int J Mol Sci 2021;22:10774. [PMID: 34639131 DOI: 10.3390/ijms221910774] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
43 Chang Y, Han JA, Kang SM, Jeong SW, Ryu T, Park HS, Yoo JJ, Lee SH, Kim SG, Kim YS, Kim HS, Jin SY, Ryu S, Jang JY. Clinical impact of serum exosomal microRNA in liver fibrosis. PLoS One 2021;16:e0255672. [PMID: 34506494 DOI: 10.1371/journal.pone.0255672] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
44 Tomlinson JE, Wolfisberg R, Fahnøe U, Patel RS, Trivedi S, Kumar A, Sharma H, Nielsen L, McDonough SP, Bukh J, Tennant BC, Kapoor A, Rosenberg BR, Rice CM, Divers TJ, Van de Walle GR, Scheel TKH. Pathogenesis, MicroRNA-122 Gene-Regulation, and Protective Immune Responses After Acute Equine Hepacivirus Infection. Hepatology 2021;74:1148-63. [PMID: 33713356 DOI: 10.1002/hep.31802] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
45 Zobeiri M, Parvizi F, Kalhori MR, Majnooni MB, Farzaei MH, Abdollahi M. Targeting miRNA by Natural Products: A Novel Therapeutic Approach for Nonalcoholic Fatty Liver. Evid Based Complement Alternat Med 2021;2021:6641031. [PMID: 34426744 DOI: 10.1155/2021/6641031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
46 Shi Y, Liu Z, Lin Q, Luo Q, Cen Y, Li J, Fang X, Gong C. MiRNAs and Cancer: Key Link in Diagnosis and Therapy. Genes (Basel) 2021;12:1289. [PMID: 34440464 DOI: 10.3390/genes12081289] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
47 Wolinska E, Skrzypczak M. Epigenetic Changes Affecting the Development of Hepatocellular Carcinoma. Cancers (Basel) 2021;13:4237. [PMID: 34439391 DOI: 10.3390/cancers13164237] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
48 Rossetti M, Stella L, Morlà‐folch J, Bobone S, Boloix A, Baranda L, Moscone D, Roldán M, Veciana J, Segura MF, Köber M, Ventosa N, Porchetta A. Engineering DNA‐Grafted Quatsomes as Stable Nucleic Acid‐Responsive Fluorescent Nanovesicles. Adv Funct Materials 2021;31:2103511. [DOI: 10.1002/adfm.202103511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
49 Li T, Zhu L, Zhu L, Wang P, Xu W, Huang J. Recent Developments in Delivery of MicroRNAs Utilizing Nanosystems for Metabolic Syndrome Therapy. Int J Mol Sci 2021;22:7855. [PMID: 34360621 DOI: 10.3390/ijms22157855] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
50 Formichi C, Nigi L, Grieco GE, Maccora C, Fignani D, Brusco N, Licata G, Sebastiani G, Dotta F. Non-Coding RNAs: Novel Players in Insulin Resistance and Related Diseases. Int J Mol Sci 2021;22:7716. [PMID: 34299336 DOI: 10.3390/ijms22147716] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
51 Franco S, Buccione D, Tural C, Martinez MA. Circulating microRNA signatures that predict liver fibrosis progression in patients with HIV-1/hepatitis C virus coinfections. AIDS 2021;35:1355-63. [PMID: 33813557 DOI: 10.1097/QAD.0000000000002895] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
52 Juanola O, Martínez-López S, Francés R, Gómez-Hurtado I. Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors. Int J Environ Res Public Health 2021;18:5227. [PMID: 34069012 DOI: 10.3390/ijerph18105227] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
53 Cossiga V, Lembo V, Nigro C, Mirra P, Miele C, D'Argenio V, Leone A, Mazzone G, Veneruso I, Guido M, Beguinot F, Caporaso N, Morisco F. The Combination of Berberine, Tocotrienols and Coffee Extracts Improves Metabolic Profile and Liver Steatosis by the Modulation of Gut Microbiota and Hepatic miR-122 and miR-34a Expression in Mice. Nutrients 2021;13:1281. [PMID: 33924725 DOI: 10.3390/nu13041281] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
54 Wang X, He Y, Mackowiak B, Gao B. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. Gut 2021;70:784-95. [PMID: 33127832 DOI: 10.1136/gutjnl-2020-322526] [Cited by in Crossref: 117] [Cited by in F6Publishing: 120] [Article Influence: 58.5] [Reference Citation Analysis]
55 Ju C, Wang M, Tak E, Kim B, Emontzpohl C, Yang Y, Yuan X, Kutay H, Liang Y, Hall DR, Dar WA, Bynon JS, Carmeliet P, Ghoshal K, Eltzschig HK. Hypoxia-inducible factor-1α-dependent induction of miR122 enhances hepatic ischemia tolerance. J Clin Invest 2021;131:140300. [PMID: 33792566 DOI: 10.1172/JCI140300] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
56 Chowdhary V, Biswas P, Ghoshal K. Role of Noncoding RNAs in Acetaminophen-Induced Liver Injury. Gene Expr 2021;20:179-88. [PMID: 33757622 DOI: 10.3727/105221621X16165282414118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Aghel N, Gustafson D, Di Meo A, Music M, Prassas I, Seidman MA, Hansen AR, Thavendiranathan P, Diamandis EP, Delgado D, Fish JE. Recurrent Myocarditis Induced by Immune-Checkpoint Inhibitor Treatment Is Accompanied by Persistent Inflammatory Markers Despite Immunosuppressive Treatment. JCO Precis Oncol 2021;5:PO. [PMID: 34337287 DOI: 10.1200/PO.20.00370] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
58 Ge X, Xie H, Wang L, Li R, Zhang F, Xu J, Zhao B, Du J. MicroRNA-122 promotes apoptosis of keratinocytes in oral lichen planus through suppressing VDR expression. J Cell Mol Med 2021;25:3400-7. [PMID: 33656264 DOI: 10.1111/jcmm.16418] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
59 Galicia-Moreno M, Silva-Gomez JA, Lucano-Landeros S, Santos A, Monroy-Ramirez HC, Armendariz-Borunda J. Liver Cancer: Therapeutic Challenges and the Importance of Experimental Models. Can J Gastroenterol Hepatol 2021;2021:8837811. [PMID: 33728291 DOI: 10.1155/2021/8837811] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
60 Li LJ, Chang WM, Hsiao M. Aberrant Expression of microRNA Clusters in Head and Neck Cancer Development and Progression: Current and Future Translational Impacts. Pharmaceuticals (Basel) 2021;14:194. [PMID: 33673471 DOI: 10.3390/ph14030194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
61 Morishita A, Oura K, Tadokoro T, Fujita K, Tani J, Masaki T. MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review. Cancers (Basel) 2021;13:514. [PMID: 33572780 DOI: 10.3390/cancers13030514] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
62 Ohishi T, Fukutomi R, Shoji Y, Goto S, Isemura M. The Beneficial Effects of Principal Polyphenols from Green Tea, Coffee, Wine, and Curry on Obesity. Molecules 2021;26:453. [PMID: 33467101 DOI: 10.3390/molecules26020453] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
63 Muciño-Olmos EA, Vázquez-Jiménez A, López-Esparza DE, Maldonado V, Valverde M, Resendis-Antonio O. MicroRNAs Regulate Metabolic Phenotypes During Multicellular Tumor Spheroids Progression. Front Oncol 2020;10:582396. [PMID: 33425736 DOI: 10.3389/fonc.2020.582396] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Jia YC, Ding YX, Mei WT, Wang YT, Zheng Z, Qu YX, Liang K, Li J, Cao F, Li F. Extracellular vesicles and pancreatitis: mechanisms, status and perspectives. Int J Biol Sci 2021;17:549-61. [PMID: 33613112 DOI: 10.7150/ijbs.54858] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
65 Wade H, Su Q. microRNAs in Nutritional Signaling and Metabolic Syndrome. Comprehensive Foodomics 2021. [DOI: 10.1016/b978-0-08-100596-5.22723-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Broermann A, Schmid R, Gabrielyan O, Sakowski M, Eisele C, Keller S, Wolff M, Baum P, Stierstorfer B, Huber J, Krämer BK, Hocher B, Streicher R, Delić D. Exosomal miRNAs as Potential Biomarkers to Monitor Phosphodiesterase 5 Inhibitor Induced Anti-Fibrotic Effects on CCl4 Treated Rats. Int J Mol Sci 2020;22:E382. [PMID: 33396535 DOI: 10.3390/ijms22010382] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
67 Loureiro D, Tout I, Narguet S, Benazzouz SM, Mansouri A, Asselah T. miRNAs as Potential Biomarkers for Viral Hepatitis B and C. Viruses 2020;12:E1440. [PMID: 33327640 DOI: 10.3390/v12121440] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
68 Umezu T, Tsuneyama K, Kanekura K, Hayakawa M, Tanahashi T, Kawano M, Taguchi YH, Toyoda H, Tamori A, Kuroda M, Murakami Y. Comprehensive analysis of liver and blood miRNA in precancerous conditions. Sci Rep 2020;10:21766. [PMID: 33303811 DOI: 10.1038/s41598-020-78500-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
69 Xu X, Chen Y, Zhu D, Zhao T, Xu R, Wang J, Hu L, Shen X. FX5 as a non-steroidal GR antagonist improved glucose homeostasis in type 2 diabetic mice via GR/HNF4α/miR-122-5p pathway. Aging (Albany NY) 2020;13:2436-58. [PMID: 33316780 DOI: 10.18632/aging.202275] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
70 Hong W, Li S, Cai Y, Zhang T, Yang Q, He B, Yu J, Chen Z. The Target MicroRNAs and Potential Underlying Mechanisms of Yiqi-Bushen-Tiaozhi Recipe against-Non-Alcoholic Steatohepatitis. Front Pharmacol 2020;11:529553. [PMID: 33281601 DOI: 10.3389/fphar.2020.529553] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
71 Suzuki T, Adachi S, Kikuguchi C, Shibata S, Nishijima S, Kawamoto Y, Iizuka Y, Koseki H, Okano H, Natsume T, Yamamoto T. Regulation of Fetal Genes by Transitions among RNA-Binding Proteins during Liver Development. Int J Mol Sci 2020;21:E9319. [PMID: 33297405 DOI: 10.3390/ijms21239319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
72 Fernandes J, Miranda RL, de Lemos ERS, Guterres A. MicroRNAs and Mammarenaviruses: Modulating Cellular Metabolism. Cells 2020;9:E2525. [PMID: 33238430 DOI: 10.3390/cells9112525] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Oura K, Morishita A, Masaki T. Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review. Int J Mol Sci 2020;21:E8362. [PMID: 33171811 DOI: 10.3390/ijms21218362] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 10.3] [Reference Citation Analysis]
74 Telichko AV, Wang H, Bachawal S, Kumar SU, Bose JC, Paulmurugan R, Dahl JJ. Therapeutic Ultrasound Parameter Optimization for Drug Delivery Applied to a Murine Model of Hepatocellular Carcinoma. Ultrasound Med Biol 2021;47:309-22. [PMID: 33153807 DOI: 10.1016/j.ultrasmedbio.2020.09.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
75 Jonas W, Schürmann A. Genetic and epigenetic factors determining NAFLD risk. Mol Metab 2021;50:101111. [PMID: 33160101 DOI: 10.1016/j.molmet.2020.101111] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
76 Cruz-Gil S, Fernández LP, Sánchez-Martínez R, Gómez de Cedrón M, Ramírez de Molina A. Non-Coding and Regulatory RNAs as Epigenetic Remodelers of Fatty Acid Homeostasis in Cancer. Cancers (Basel) 2020;12:E2890. [PMID: 33050166 DOI: 10.3390/cancers12102890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
77 Singh G, Yoshida EM, Rathi S, Marquez V, Kim P, Erb SR, Salh BS. Biomarkers for hepatocellular cancer. World J Hepatol 2020; 12(9): 558-573 [PMID: 33033565 DOI: 10.4254/wjh.v12.i9.558] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
78 Brennan MÁ, Layrolle P, Mooney DJ. Biomaterials functionalized with MSC secreted extracellular vesicles and soluble factors for tissue regeneration. Adv Funct Mater 2020;30:1909125. [PMID: 32952493 DOI: 10.1002/adfm.201909125] [Cited by in Crossref: 92] [Cited by in F6Publishing: 102] [Article Influence: 30.7] [Reference Citation Analysis]
79 Chai C, Cox B, Yaish D, Gross D, Rosenberg N, Amblard F, Shemuelian Z, Gefen M, Korach A, Tirosh O, Lanton T, Link H, Tam J, Permyakova A, Ozhan G, Citrin J, Liao H, Tannous M, Hahn M, Axelrod J, Arretxe E, Alonso C, Martinez-Arranz I, Betés PO, Safadi R, Salhab A, Amer J, Tber Z, Mengshetti S, Giladi H, Schinazi RF, Galun E. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122. Gastroenterology 2020;159:999-1014.e9. [PMID: 32450149 DOI: 10.1053/j.gastro.2020.05.056] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
80 Kunden RD, Khan JQ, Ghezelbash S, Wilson JA. The Role of the Liver-Specific microRNA, miRNA-122 in the HCV Replication Cycle. Int J Mol Sci. 2020;21. [PMID: 32784807 DOI: 10.3390/ijms21165677] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
81 Teng KY, Barajas JM, Hu P, Jacob ST, Ghoshal K. Role of B Cell Lymphoma 2 in the Regulation of Liver Fibrosis in miR-122 Knockout Mice. Biology (Basel) 2020;9:E157. [PMID: 32650615 DOI: 10.3390/biology9070157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
82 Ono C, Fukuhara T, Li S, Wang J, Sato A, Izumi T, Fauzyah Y, Yamamoto T, Morioka Y, Dokholyan NV, Standley DM, Matsuura Y. Various miRNAs compensate the role of miR-122 on HCV replication. PLoS Pathog. 2020;16:e1008308. [PMID: 32574204 DOI: 10.1371/journal.ppat.1008308] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
83 Monga SP. Inside-Out or Outside-In: Choosing the Right Model of Hepatocellular Cancer. Gene Expr 2020;20:139-45. [PMID: 32503685 DOI: 10.3727/105221620X15913805462476] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
84 Mitash N, E Donovan J, Swiatecka-Urban A. The Role of MicroRNA in the Airway Surface Liquid Homeostasis. Int J Mol Sci 2020;21:E3848. [PMID: 32481719 DOI: 10.3390/ijms21113848] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
85 Slack FJ, Chinnaiyan AM. The Role of Non-coding RNAs in Oncology. Cell 2019;179:1033-55. [PMID: 31730848 DOI: 10.1016/j.cell.2019.10.017] [Cited by in Crossref: 521] [Cited by in F6Publishing: 563] [Article Influence: 173.7] [Reference Citation Analysis]
86 Rajesh Y, Sarkar D. Molecular Mechanisms Regulating Obesity-Associated Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E1290. [PMID: 32443737 DOI: 10.3390/cancers12051290] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
87 Manna D, Sarkar D. Non-Coding RNAs: Regulating Disease Progression and Therapy Resistance in Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E1243. [PMID: 32429062 DOI: 10.3390/cancers12051243] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
88 Glaser T, Baiocchi L, Zhou T, Francis H, Lenci I, Grassi G, Kennedy L, Liangpunsakul S, Glaser S, Alpini G, Meng F. Pro-inflammatory signalling and gut-liver axis in non-alcoholic and alcoholic steatohepatitis: Differences and similarities along the path. J Cell Mol Med. 2020;24:5955-5965. [PMID: 32314869 DOI: 10.1111/jcmm.15182] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
89 Takahashi A, Suzuki T, Soeda S, Takaoka S, Kobori S, Yamaguchi T, Mohamed HMA, Yanagiya A, Abe T, Shigeta M, Furuta Y, Kuba K, Yamamoto T. The CCR4-NOT complex maintains liver homeostasis through mRNA deadenylation. Life Sci Alliance 2020;3:e201900494. [PMID: 32238456 DOI: 10.26508/lsa.201900494] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
90 Hu M, Huang X, Han X, Ji L. Loss of HNF1α Function Contributes to Hepatocyte Proliferation and Abnormal Cholesterol Metabolism via Downregulating miR-122: A Novel Mechanism of MODY3. Diabetes Metab Syndr Obes 2020;13:627-39. [PMID: 32184642 DOI: 10.2147/DMSO.S236915] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
91 Yin L, Keeler GD, Zhang Y, Hoffman BE, Ling C, Qing K, Srivastava A. AAV3-miRNA vectors for growth suppression of human hepatocellular carcinoma cells in vitro and human liver tumors in a murine xenograft model in vivo. Gene Ther 2021;28:422-34. [PMID: 32152434 DOI: 10.1038/s41434-020-0140-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
92 Jin X, Gao J, Zheng R, Yu M, Ren Y, Yan T, Huang Y, Li Y. Antagonizing circRNA_002581-miR-122-CPEB1 axis alleviates NASH through restoring PTEN-AMPK-mTOR pathway regulated autophagy. Cell Death Dis 2020;11:123. [PMID: 32054840 DOI: 10.1038/s41419-020-2293-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
93 Delgado ER, Stahl EC, Roy N, Wilkinson PD, Duncan AW. Polyploidy in Liver Function, Mitochondrial Metabolism, and Cancer. The Liver 2020. [DOI: 10.1002/9781119436812.ch47] [Reference Citation Analysis]
94 Lim JY, Wang XD. Mechanistic understanding of β-cryptoxanthin and lycopene in cancer prevention in animal models. Biochim Biophys Acta Mol Cell Biol Lipids 2020;1865:158652. [PMID: 32035228 DOI: 10.1016/j.bbalip.2020.158652] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
95 Gallo A, Miceli V, Bulati M, Iannolo G, Contino F, Conaldi PG. Viral miRNAs as Active Players and Participants in Tumorigenesis. Cancers (Basel) 2020;12:E358. [PMID: 32033193 DOI: 10.3390/cancers12020358] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
96 Biju BM, Chhabra SS, Sarkar C. Elucidation of novel miRNA candidates and their role in unraveling the pathology of Non-Alcoholic Fatty Liver Disease.. [DOI: 10.1101/2020.01.31.917831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
97 Wischhusen JC, Chowdhury SM, Lee T, Wang H, Bachawal S, Devulapally R, Afjei R, Sukumar UK, Paulmurugan R. Ultrasound-mediated delivery of miRNA-122 and anti-miRNA-21 therapeutically immunomodulates murine hepatocellular carcinoma in vivo. J Control Release 2020;321:272-84. [PMID: 32004588 DOI: 10.1016/j.jconrel.2020.01.051] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
98 Ono C, Fukuhara T, Li S, Wang J, Sato A, Izumi T, Fauzyah Y, Yamamoto T, Morioka Y, Dokholyan NV, Standley DM, Matsuura Y. Various miRNAs are involved in efficient HCV replication.. [DOI: 10.1101/2020.01.10.901488] [Reference Citation Analysis]
99 Sengupta D, Cassel T, Teng KY, Aljuhani M, Chowdhary VK, Hu P, Zhang X, Fan TW, Ghoshal K. Regulation of hepatic glutamine metabolism by miR-122. Mol Metab 2020;34:174-86. [PMID: 32180557 DOI: 10.1016/j.molmet.2020.01.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
100 Cheng Q, Wang L. LncRNA XIST serves as a ceRNA to regulate the expression of ASF1A, BRWD1M, and PFKFB2 in kidney transplant acute kidney injury via sponging hsa-miR-212-3p and hsa-miR-122-5p. Cell Cycle 2020;19:290-9. [PMID: 31914881 DOI: 10.1080/15384101.2019.1707454] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
101 Valenti L, Pelusi S. The Natural History of NAFLD: Environmental vs. Genetic Risk Factors. Non-Alcoholic Fatty Liver Disease 2020. [DOI: 10.1007/978-3-319-95828-6_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
102 El Sharkawy R, George J, Eslam M. Genes and NAFLD/NASH Progression. NAFLD and NASH 2020. [DOI: 10.1007/978-3-030-37173-9_3] [Reference Citation Analysis]
103 Jiménez-Alesanco A, Marcuello M, Pastor-Jiménez M, López-Puerto L, Bonjoch L, Gironella M, Carrascal M, Abian J, de-Madaria E, Closa D. Acute pancreatitis promotes the generation of two different exosome populations. Sci Rep 2019;9:19887. [PMID: 31882721 DOI: 10.1038/s41598-019-56220-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
104 Murata Y, Yamashiro T, Kessoku T, Jahan I, Usuda H, Tanaka T, Okamoto T, Nakajima A, Wada K. Up-Regulated MicroRNA-27b Promotes Adipocyte Differentiation via Induction of Acyl-CoA Thioesterase 2 Expression. Biomed Res Int 2019;2019:2916243. [PMID: 31930115 DOI: 10.1155/2019/2916243] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
105 Wang H, Lu Z, Zhao X. Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer. J Hematol Oncol. 2019;12:133. [PMID: 31815633 DOI: 10.1186/s13045-019-0806-6] [Cited by in Crossref: 89] [Cited by in F6Publishing: 103] [Article Influence: 22.3] [Reference Citation Analysis]
106 Fornari F, Gramantieri L, Callegari E, Shankaraiah RC, Piscaglia F, Negrini M, Giovannini C. MicroRNAs in Animal Models of HCC. Cancers (Basel) 2019;11:E1906. [PMID: 31805631 DOI: 10.3390/cancers11121906] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
107 Gholami M, Larijani B, Zahedi Z, Mahmoudian F, Bahrami S, Omran SP, Saadatian Z, Hasani-Ranjbar S, Taslimi R, Bastami M, Amoli MM. Inflammation related miRNAs as an important player between obesity and cancers. J Diabetes Metab Disord 2019;18:675-92. [PMID: 31890692 DOI: 10.1007/s40200-019-00459-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
108 Kim KH, Lee JI, Kim OH, Hong HE, Kwak BJ, Choi HJ, Ahn J, Lee TY, Lee SC, Kim SJ. Ameliorating liver fibrosis in an animal model using the secretome released from miR-122-transfected adipose-derived stem cells. World J Stem Cells 2019; 11(11): 990-1004 [PMID: 31768225 DOI: 10.4252/wjsc.v11.i11.990] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
109 Piccinin E, Arconzo M, Graziano G, Vacca M, Peres C, Bellafante E, Villani G, Moschetta A. Hepatic microRNA Expression by PGC-1α and PGC-1β in the Mouse. Int J Mol Sci 2019;20:E5735. [PMID: 31731670 DOI: 10.3390/ijms20225735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
110 Shankaraiah RC, Gramantieri L, Fornari F, Sabbioni S, Callegari E, Negrini M. Animal Models of Hepatocellular Carcinoma Prevention. Cancers (Basel) 2019;11:E1792. [PMID: 31739536 DOI: 10.3390/cancers11111792] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
111 O'Brien A, Zhou T, Tan C, Alpini G, Glaser S. Role of Non-Coding RNAs in the Progression of Liver Cancer: Evidence from Experimental Models. Cancers (Basel) 2019;11:E1652. [PMID: 31731549 DOI: 10.3390/cancers11111652] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
112 Klieser E, Mayr C, Kiesslich T, Wissniowski T, Fazio PD, Neureiter D, Ocker M. The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications. Int J Mol Sci 2019;20:E5266. [PMID: 31652839 DOI: 10.3390/ijms20215266] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
113 Li Y, Carrillo JA, Ding Y, He Y, Zhao C, Liu J, Zan L, Song J. DNA methylation, microRNA expression profiles and their relationships with transcriptome in grass-fed and grain-fed Angus cattle rumen tissue. PLoS One 2019;14:e0214559. [PMID: 31622349 DOI: 10.1371/journal.pone.0214559] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
114 Ha SY, Yu JI, Choi C, Kang SY, Joh JW, Paik SW, Kim S, Kim M, Park HC, Park CK. Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma. Sci Rep 2019;9:14738. [PMID: 31611609 DOI: 10.1038/s41598-019-50594-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
115 Zeng C, Sang Y, Wang FY, Zhuang SM. Opposing roles of C/EBPα and eEF1A1 in Sp1-regulated miR-122 transcription. RNA Biol 2020;17:202-10. [PMID: 31561740 DOI: 10.1080/15476286.2019.1673656] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
116 Liu SY. Abnormal regulation of non-coding RNAs plays a role in development and progression of hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2019; 27(18): 1107-1113 [DOI: 10.11569/wcjd.v27.i18.1107] [Reference Citation Analysis]
117 Aydin Y, Kurt R, Song K, Lin D, Osman H, Youngquist B, Scott JW, Shores NJ, Thevenot P, Cohen A, Dash S. Hepatic Stress Response in HCV Infection Promotes STAT3-Mediated Inhibition of HNF4A-miR-122 Feedback Loop in Liver Fibrosis and Cancer Progression. Cancers (Basel) 2019;11:E1407. [PMID: 31547152 DOI: 10.3390/cancers11101407] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
118 Shang W, Adzika GK, Li Y, Huang Q, Ding N, Chinembiri B, Rashid MS, Machuki JO. Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma. Cancer Med 2019;8:6684-99. [PMID: 31523930 DOI: 10.1002/cam4.2553] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
119 Nobili V, Alisi A, Valenti L, Miele L, Feldstein AE, Alkhouri N. NAFLD in children: new genes, new diagnostic modalities and new drugs. Nat Rev Gastroenterol Hepatol 2019;16:517-30. [PMID: 31278377 DOI: 10.1038/s41575-019-0169-z] [Cited by in Crossref: 120] [Cited by in F6Publishing: 117] [Article Influence: 30.0] [Reference Citation Analysis]
120 Mahmoudian-Sani MR, Asgharzade S, Alghasi A, Saeedi-Boroujeni A, Adnani Sadati SJ, Moradi MT. MicroRNA-122 in patients with hepatitis B and hepatitis B virus-associated hepatocellular carcinoma. J Gastrointest Oncol 2019;10:789-96. [PMID: 31392060 DOI: 10.21037/jgo.2019.02.14] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
121 Sutaria DS, Jiang J, Azevedo-Pouly AC, Wright L, Bray JA, Fredenburg K, Liu X, Lu J, Torres C, Mancinelli G, Grippo PJ, Coppola V, Schmittgen TD. Knockout of Acinar Enriched microRNAs in Mice Promote Duct Formation But Not Pancreatic Cancer. Sci Rep 2019;9:11147. [PMID: 31367007 DOI: 10.1038/s41598-019-47566-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
122 Li P, Chen Y, Juma CA, Yang C, Huang J, Zhang X, Zeng Y. Differential Inhibition of Target Gene Expression by Human microRNAs. Cells 2019;8:E791. [PMID: 31366019 DOI: 10.3390/cells8080791] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
123 Lowey B, Hertz L, Chiu S, Valdez K, Li Q, Liang TJ. Hepatitis C Virus Infection Induces Hepatic Expression of NF-κB-Inducing Kinase and Lipogenesis by Downregulating miR-122. mBio 2019;10:e01617-19. [PMID: 31363036 DOI: 10.1128/mBio.01617-19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
124 Terletskiy OM, Kolomiytsev VI, Lukavetskiy OV, Bufan MM. PERSPECTIVE FOR EVALUATION OF MICRORNA IN PLASMA AND BILE FOR DIFFERENTIAL DIAGNOSIS OF OBSTRUCTIVE BILIARY TRACT DISEASE. Wiad Lek 2019;72:1403-1407. [DOI: 10.36740/wlek201907130] [Reference Citation Analysis]
125 Starlinger P, Hackl H, Pereyra D, Skalicky S, Geiger E, Finsterbusch M, Tamandl D, Brostjan C, Grünberger T, Hackl M, Assinger A. Predicting Postoperative Liver Dysfunction Based on Blood-Derived MicroRNA Signatures. Hepatology 2019;69:2636-51. [PMID: 30779441 DOI: 10.1002/hep.30572] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
126 Toh TB, Lim JJ, Chow EK. Epigenetics of hepatocellular carcinoma. Clin Transl Med. 2019;8:13. [PMID: 31056726 DOI: 10.1186/s40169-019-0230-0] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 14.3] [Reference Citation Analysis]
127 Sayad A, Taheri M, Arsang-Jang S, Glassy MC, Ghafouri-Fard S. Hepatocellular carcinoma up-regulated long non-coding RNA: a putative marker in multiple sclerosis. Metab Brain Dis. 2019;34:1201-1205. [PMID: 31049796 DOI: 10.1007/s11011-019-00418-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
128 Dar WA, Sullivan E, Bynon JS, Eltzschig H, Ju C. Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms. Liver Int 2019;39:788-801. [PMID: 30843314 DOI: 10.1111/liv.14091] [Cited by in Crossref: 122] [Cited by in F6Publishing: 119] [Article Influence: 30.5] [Reference Citation Analysis]
129 Sanduzzi-Zamparelli M, Boix L, Leal C, Reig M. Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents. Viruses 2019;11:E406. [PMID: 31052463 DOI: 10.3390/v11050406] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
130 Flamant S, Chomel JC, Desterke C, Féraud O, Gobbo E, Mitjavila-Garcia MT, Foudi A, Griscelli F, Turhan AG, Bennaceur-Griscelli A. Global MicroRNA Profiling Uncovers miR-206 as a Negative Regulator of Hematopoietic Commitment in Human Pluripotent Stem Cells. Int J Mol Sci 2019;20:E1737. [PMID: 30965622 DOI: 10.3390/ijms20071737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
131 Sulaiman SA, Muhsin NIA, Jamal R. Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver Disease. Front Physiol 2019;10:279. [PMID: 30941061 DOI: 10.3389/fphys.2019.00279] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 9.0] [Reference Citation Analysis]
132 Li Y, Carrillo JA, Ding Y, He Y, Zhao C, Liu J, Zan L, Song J. DNA methylation, microRNA expression profiles and their relationships with transcriptome in grass-fed and grain-fed Angus Cattle rumen tissue.. [DOI: 10.1101/581421] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
133 Kanda T, Goto T, Hirotsu Y, Moriyama M, Omata M. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review. Int J Mol Sci. 2019;20. [PMID: 30889843 DOI: 10.3390/ijms] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
134 Kanda T, Goto T, Hirotsu Y, Moriyama M, Omata M. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review. Int J Mol Sci. 2019;20. [PMID: 30889843 DOI: 10.3390/ijms20061358] [Cited by in Crossref: 105] [Cited by in F6Publishing: 123] [Article Influence: 26.3] [Reference Citation Analysis]
135 Martens CR, Bansal SS, Accornero F. Cardiovascular inflammation: RNA takes the lead. J Mol Cell Cardiol 2019;129:247-56. [PMID: 30880251 DOI: 10.1016/j.yjmcc.2019.03.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
136 Wang Y, Liang H, Jin F, Yan X, Xu G, Hu H, Liang G, Zhan S, Hu X, Zhao Q, Liu Y, Jiang ZY, Zhang CY, Chen X, Zen K. Injured liver-released miRNA-122 elicits acute pulmonary inflammation via activating alveolar macrophage TLR7 signaling pathway. Proc Natl Acad Sci U S A 2019;116:6162-71. [PMID: 30867286 DOI: 10.1073/pnas.1814139116] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
137 Huang R, Duan X, Fan J, Li G, Wang B. Role of Noncoding RNA in Development of Nonalcoholic Fatty Liver Disease. Biomed Res Int 2019;2019:8690592. [PMID: 30931332 DOI: 10.1155/2019/8690592] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
138 Suzuki T, Kikuguchi C, Nishijima S, Nagashima T, Takahashi A, Okada M, Yamamoto T. Postnatal liver functional maturation requires Cnot complex-mediated decay of mRNAs encoding cell cycle and immature liver genes. Development 2019;146:dev168146. [PMID: 30733279 DOI: 10.1242/dev.168146] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
139 Ye J, Zou M, Li P, Liu H. MicroRNA Regulation of Energy Metabolism to Induce Chemoresistance in Cancers. Technol Cancer Res Treat 2018;17:1533033818805997. [PMID: 30444190 DOI: 10.1177/1533033818805997] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
140 Xu H, Xu SJ, Xie SJ, Zhang Y, Yang JH, Zhang WQ, Zheng MN, Zhou H, Qu LH. MicroRNA-122 supports robust innate immunity in hepatocytes by targeting the RTKs/STAT3 signaling pathway. Elife 2019;8:e41159. [PMID: 30735121 DOI: 10.7554/eLife.41159] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
141 Turato C, Fornari F, Pollutri D, Fassan M, Quarta S, Villano G, Ruvoletto M, Bolondi L, Gramantieri L, Pontisso P. MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma. J Clin Med. 2019;8. [PMID: 30717317 DOI: 10.3390/jcm8020171] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
142 Bartel DP. Metazoan MicroRNAs. Cell 2018;173:20-51. [PMID: 29570994 DOI: 10.1016/j.cell.2018.03.006] [Cited by in Crossref: 1798] [Cited by in F6Publishing: 1442] [Article Influence: 449.5] [Reference Citation Analysis]
143 Yang YM, Kim SY, Seki E. Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets. Semin Liver Dis. 2019;39:26-42. [PMID: 30809789 DOI: 10.1055/s-0038-1676806] [Cited by in Crossref: 130] [Cited by in F6Publishing: 114] [Article Influence: 32.5] [Reference Citation Analysis]
144 Damas ND, Fossat N, Scheel TKH. Functional Interplay between RNA Viruses and Non-Coding RNA in Mammals. Noncoding RNA 2019;5:E7. [PMID: 30646609 DOI: 10.3390/ncrna5010007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
145 Dhanasekaran R, Nault JC, Roberts LR, Zucman-Rossi J. Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy. Gastroenterology 2019;156:492-509. [PMID: 30404026 DOI: 10.1053/j.gastro.2018.11.001] [Cited by in Crossref: 101] [Cited by in F6Publishing: 107] [Article Influence: 25.3] [Reference Citation Analysis]
146 Georgiou S, Pantazopoulou V, Anastasiadou E. The Role of microRNAs in the Gut-Liver Axis. The Human Gut-Liver-Axis in Health and Disease 2019. [DOI: 10.1007/978-3-319-98890-0_13] [Reference Citation Analysis]
147 Cai CX, Carlos S, Solaimani P, Trivedi BJ, Tran C, Castelino-prabhu S. Nutritional and Dietary Interventions for Nonalcoholic Fatty Liver Disease. Dietary Interventions in Liver Disease 2019. [DOI: 10.1016/b978-0-12-814466-4.00029-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
148 Valdmanis PN, Kim HK, Chu K, Zhang F, Xu J, Munding EM, Shen J, Kay MA. miR-122 removal in the liver activates imprinted microRNAs and enables more effective microRNA-mediated gene repression. Nat Commun 2018;9:5321. [PMID: 30552326 DOI: 10.1038/s41467-018-07786-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
149 Dongiovanni P, Meroni M, Longo M, Fargion S, Fracanzani AL. miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis. Int J Mol Sci 2018;19:E3966. [PMID: 30544653 DOI: 10.3390/ijms19123966] [Cited by in Crossref: 67] [Cited by in F6Publishing: 76] [Article Influence: 13.4] [Reference Citation Analysis]
150 Pascut D, Tamini S, Bresolin S, Giraudi P, Basso G, Minocci A, Tiribelli C, Grugni G, Sartorio A. Differences in circulating microRNA signature in Prader-Willi syndrome and non-syndromic obesity. Endocr Connect 2018;7:1262-74. [PMID: 30352401 DOI: 10.1530/EC-18-0329] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
151 Chen QQ, Zhang C, Qin MQ, Li J, Wang H, Xu DX, Wang JQ. Inositol-Requiring Enzyme 1 Alpha Endoribonuclease Specific Inhibitor STF-083010 Alleviates Carbon Tetrachloride Induced Liver Injury and Liver Fibrosis in Mice. Front Pharmacol 2018;9:1344. [PMID: 30538632 DOI: 10.3389/fphar.2018.01344] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
152 Febbraio MA, Reibe S, Shalapour S, Ooi GJ, Watt MJ, Karin M. Preclinical Models for Studying NASH-Driven HCC: How Useful Are They? Cell Metab 2019;29:18-26. [PMID: 30449681 DOI: 10.1016/j.cmet.2018.10.012] [Cited by in Crossref: 100] [Cited by in F6Publishing: 107] [Article Influence: 20.0] [Reference Citation Analysis]
153 Duan X, Jiang B, Yang J, Zhou L, Tian B, Mao X. FOXP3 inhibits MYC expression via regulating miR-198 and influences cell viability, proliferation and cell apoptosis in HepG2. Cancer Med 2018;7:6182-92. [PMID: 30378283 DOI: 10.1002/cam4.1780] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
154 Shi J, Ye G, Zhao G, Wang X, Ye C, Thammavong K, Xu J, Dong J. Coordinative control of G2/M phase of the cell cycle by non-coding RNAs in hepatocellular carcinoma. PeerJ 2018;6:e5787. [PMID: 30364632 DOI: 10.7717/peerj.5787] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
155 Jovanovic-cupic S, Bozovic A, Krajnovic M, Petrovic N. Hepatitis C: Host and Viral Factors Associated with Response to Therapy and Progression of Liver Fibrosis. Hepatitis C - From Infection to Cure 2018. [DOI: 10.5772/intechopen.76417] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
156 Yan X, Wang Z, Bishop CA, Weitkunat K, Feng X, Tarbier M, Luo J, Friedländer MR, Burkhardt R, Klaus S, Willnow TE, Poy MN. Control of hepatic gluconeogenesis by Argonaute2. Mol Metab 2018;18:15-24. [PMID: 30348590 DOI: 10.1016/j.molmet.2018.10.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
157 Wen DY, Huang JC, Wang JY, Pan WY, Zeng JH, Pang YY, Yang H. Potential clinical value and putative biological function of miR-122-5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data. Oncol Lett 2018;16:6918-29. [PMID: 30546424 DOI: 10.3892/ol.2018.9523] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
158 Sagnelli E, Potenza N, Onorato L, Sagnelli C, Coppola N, Russo A. Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma. World J Hepatol 2018; 10(9): 558-570 [PMID: 30310534 DOI: 10.4254/wjh.v10.i9.558] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
159 Li CW, Chiu YK, Chen BS. Investigating Pathogenic and Hepatocarcinogenic Mechanisms from Normal Liver to HCC by Constructing Genetic and Epigenetic Networks via Big Genetic and Epigenetic Data Mining and Genome-Wide NGS Data Identification. Dis Markers 2018;2018:8635329. [PMID: 30344796 DOI: 10.1155/2018/8635329] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
160 Wang RH, He LY, Zhou SH. The role of gene sculptor microRNAs in human precancerous lesions. Onco Targets Ther 2018;11:5667-75. [PMID: 30254459 DOI: 10.2147/OTT.S171241] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
161 Lian M, Selmi C, Gershwin ME, Ma X. Myeloid Cells and Chronic Liver Disease: a Comprehensive Review. Clin Rev Allergy Immunol. 2018;54:307-317. [PMID: 29313221 DOI: 10.1007/s12016-017-8664-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
162 Momtazi AA, Banach M, Pirro M, Stein EA, Sahebkar A. MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia? Clin Rev Allergy Immunol 2018;54:224-33. [PMID: 28534160 DOI: 10.1007/s12016-017-8611-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
163 Janas MM, Harbison CE, Perry VK, Carito B, Sutherland JE, Vaishnaw AK, Keirstead ND, Warner G. The Nonclinical Safety Profile of GalNAc-conjugated RNAi Therapeutics in Subacute Studies. Toxicol Pathol 2018;46:735-45. [PMID: 30139307 DOI: 10.1177/0192623318792537] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
164 Bernier A, Sagan SM. The Diverse Roles of microRNAs at the Host⁻Virus Interface. Viruses 2018;10:E440. [PMID: 30126238 DOI: 10.3390/v10080440] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 11.4] [Reference Citation Analysis]
165 Wang M, Yu F, Li P. Circular RNAs: Characteristics, Function and Clinical Significance in Hepatocellular Carcinoma. Cancers (Basel) 2018;10:E258. [PMID: 30072625 DOI: 10.3390/cancers10080258] [Cited by in Crossref: 72] [Cited by in F6Publishing: 87] [Article Influence: 14.4] [Reference Citation Analysis]
166 Pu W, Li J, Zheng Y, Shen X, Fan X, Zhou JK, He J, Deng Y, Liu X, Wang C, Yang S, Chen Q, Liu L, Zhang G, Wei YQ, Peng Y. Targeting Pin1 by inhibitor API-1 regulates microRNA biogenesis and suppresses hepatocellular carcinoma development. Hepatology 2018;68:547-60. [PMID: 29381806 DOI: 10.1002/hep.29819] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
167 Sendi H, Mead I, Wan M, Mehrab-Mohseni M, Koch K, Atala A, Bonkovsky HL, Bishop CE. miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling. PLoS One. 2018;13:e0200847. [PMID: 30024933 DOI: 10.1371/journal.pone.0200847] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
168 Iravani F, Hosseini N, Mojarrad M. Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis. Middle East J Dig Dis 2018;10:213-9. [PMID: 31049168 DOI: 10.15171/mejdd.2018.113] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
169 Li L, Li X, Huang X, Jiang W, Liu L, Hou C, Yang Y, Zhang L, Zhang X, Ye L, Yuan J, Li G, Sun H, Mao L. Synergistic anticancer effects of nanocarrier loaded with berberine and miR-122. Biosci Rep 2018;38:BSR20180311. [PMID: 29769413 DOI: 10.1042/BSR20180311] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
170 Yang Y, Alderman C, Sehlaoui A, Xiao Y, Wang W. MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers. Can J Gastroenterol Hepatol 2018;2018:9740357. [PMID: 30046565 DOI: 10.1155/2018/9740357] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
171 Zhang X, Price NL, Fernández-Hernando C. Non-coding RNAs in lipid metabolism. Vascul Pharmacol 2019;114:93-102. [PMID: 29929012 DOI: 10.1016/j.vph.2018.06.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
172 Hahne JC, Valeri N. Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors. Front Oncol. 2018;8:226. [PMID: 29967761 DOI: 10.3389/fonc.2018.00226] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 7.6] [Reference Citation Analysis]
173 Gordon EM, Ravicz JR, Liu S, Chawla SP, Hall FL. Cell cycle checkpoint control: The cyclin G1/Mdm2/p53 axis emerges as a strategic target for broad-spectrum cancer gene therapy - A review of molecular mechanisms for oncologists. Mol Clin Oncol 2018;9:115-34. [PMID: 30101008 DOI: 10.3892/mco.2018.1657] [Cited by in Crossref: 28] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
174 Barajas JM, Reyes R, Guerrero MJ, Jacob ST, Motiwala T, Ghoshal K. The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer. Sci Rep. 2018;8:9105. [PMID: 29904144 DOI: 10.1038/s41598-018-27358-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
175 Sekiba K, Otsuka M, Ohno M, Yamagami M, Kishikawa T, Suzuki T, Ishibashi R, Seimiya T, Tanaka E, Koike K. Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA. World J Gastroenterol 2018; 24(21): 2261-2268 [PMID: 29881235 DOI: 10.3748/wjg.v24.i21.2261] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
176 Zhou Y, Meng X, Chen S, Li W, Li D, Singer R, Gu W. IMP1 regulates UCA1-mediated cell invasion through facilitating UCA1 decay and decreasing the sponge effect of UCA1 for miR-122-5p. Breast Cancer Res 2018;20:32. [PMID: 29669595 DOI: 10.1186/s13058-018-0959-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 7.4] [Reference Citation Analysis]
177 Li S, Yao J, Xie M, Liu Y, Zheng M. Exosomal miRNAs in hepatocellular carcinoma development and clinical responses. J Hematol Oncol 2018;11:54. [PMID: 29642941 DOI: 10.1186/s13045-018-0579-3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 8.4] [Reference Citation Analysis]
178 Su Q, Kumar V, Sud N, Mahato RI. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis. Adv Drug Deliv Rev 2018;129:54-63. [PMID: 29391222 DOI: 10.1016/j.addr.2018.01.009] [Cited by in Crossref: 68] [Cited by in F6Publishing: 73] [Article Influence: 13.6] [Reference Citation Analysis]
179 Chai C, Galun E, Giladi H. Reply. Gastroenterology 2018;154:1553-4. [PMID: 29526723 DOI: 10.1053/j.gastro.2018.03.018] [Reference Citation Analysis]
180 Ultimo S, Zauli G, Martelli AM, Vitale M, McCubrey JA, Capitani S, Neri LM. Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise. Oncotarget 2018;9:17238-54. [PMID: 29682219 DOI: 10.18632/oncotarget.24428] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
181 Crouchet E, Wrensch F, Schuster C, Zeisel MB, Baumert TF. Host-targeting therapies for hepatitis C virus infection: current developments and future applications. Therap Adv Gastroenterol 2018;11:1756284818759483. [PMID: 29619090 DOI: 10.1177/1756284818759483] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
182 Wang H, Zhang Y, Wu X, Wang Y, Cui H, Li X, Zhang J, Tun N, Peng Y, Yu J. Regulation of Human Natural Killer Cell IFN-γ Production by MicroRNA-146a via Targeting the NF-κB Signaling Pathway. Front Immunol 2018;9:293. [PMID: 29593706 DOI: 10.3389/fimmu.2018.00293] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
183 Wong CM, Tsang FH, Ng IO. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications. Nat Rev Gastroenterol Hepatol 2018;15:137-51. [PMID: 29317776 DOI: 10.1038/nrgastro.2017.169] [Cited by in Crossref: 247] [Cited by in F6Publishing: 262] [Article Influence: 49.4] [Reference Citation Analysis]
184 Kwon JJ, Willy JA, Quirin KA, Wek RC, Korc M, Yin XM, Kota J. Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential. Oncotarget 2016;7:71635-50. [PMID: 27626694 DOI: 10.18632/oncotarget.11928] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
185 Eslam M, Valenti L, Romeo S. Genetics and epigenetics of NAFLD and NASH: Clinical impact. J Hepatol 2018;68:268-79. [PMID: 29122391 DOI: 10.1016/j.jhep.2017.09.003] [Cited by in Crossref: 448] [Cited by in F6Publishing: 448] [Article Influence: 89.6] [Reference Citation Analysis]
186 Xu H, Xu S, Xie S, Zhang Y, Yang J, Zhang W, Zheng M, Zhou H, Qu L. MicroRNA-122 supports robust innate immunity in hepatocytes by suppressing STAT3 phosphorylation.. [DOI: 10.1101/250746] [Reference Citation Analysis]
187 Schueller F, Roy S, Vucur M, Trautwein C, Luedde T, Roderburg C. The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity. Int J Mol Sci. 2018;19:pii: E261. [PMID: 29337905 DOI: 10.3390/ijms19010261] [Cited by in Crossref: 68] [Cited by in F6Publishing: 56] [Article Influence: 13.6] [Reference Citation Analysis]
188 Li C, Qin F, Hu F, Xu H, Sun G, Han G, Wang T, Guo M. Characterization and selective incorporation of small non-coding RNAs in non-small cell lung cancer extracellular vesicles. Cell Biosci 2018;8:2. [PMID: 29344346 DOI: 10.1186/s13578-018-0202-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 49] [Article Influence: 8.4] [Reference Citation Analysis]
189 Billerbeck E, Wolfisberg R, Fahnøe U, Xiao JW, Quirk C, Luna JM, Cullen JM, Hartlage AS, Chiriboga L, Ghoshal K, Lipkin WI, Bukh J, Scheel TKH, Kapoor A, Rice CM. Mouse models of acute and chronic hepacivirus infection. Science 2017;357:204-8. [PMID: 28706073 DOI: 10.1126/science.aal1962] [Cited by in Crossref: 86] [Cited by in F6Publishing: 83] [Article Influence: 17.2] [Reference Citation Analysis]
190 Wang T, Pan W, Hu J, Zhang Z, Li G, Liang Y. Circular RNAs in Metabolic Diseases. Adv Exp Med Biol 2018;1087:275-85. [PMID: 30259374 DOI: 10.1007/978-981-13-1426-1_22] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
191 Ying Z, Chen T. Cross Talk Between Noncoding RNAs and DNA Methylation and Demethylation in Cancer. Cancer and Noncoding RNAs 2018. [DOI: 10.1016/b978-0-12-811022-5.00017-6] [Reference Citation Analysis]
192 Satishchandran A, Ambade A, Rao S, Hsueh YC, Iracheta-Vellve A, Tornai D, Lowe P, Gyongyosi B, Li J, Catalano D, Zhong L, Kodys K, Xie J, Bala S, Gao G, Szabo G. MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease. Gastroenterology 2018;154:238-252.e7. [PMID: 28987423 DOI: 10.1053/j.gastro.2017.09.022] [Cited by in Crossref: 87] [Cited by in F6Publishing: 88] [Article Influence: 17.4] [Reference Citation Analysis]
193 Aryal B, Singh AK, Rotllan N, Price N, Fernández-Hernando C. MicroRNAs and lipid metabolism. Curr Opin Lipidol 2017;28:273-80. [PMID: 28333713 DOI: 10.1097/MOL.0000000000000420] [Cited by in Crossref: 119] [Cited by in F6Publishing: 125] [Article Influence: 19.8] [Reference Citation Analysis]
194 Li C, Deng M, Hu J, Li X, Chen L, Ju Y, Hao J, Meng S. Chronic inflammation contributes to the development of hepatocellular carcinoma by decreasing miR-122 levels. Oncotarget. 2016;7:17021-17034. [PMID: 26933995 DOI: 10.18632/oncotarget.7740] [Cited by in Crossref: 41] [Cited by in F6Publishing: 52] [Article Influence: 6.8] [Reference Citation Analysis]
195 Singh AK, Aryal B, Zhang X, Fan Y, Price NL, Suárez Y, Fernández-Hernando C. Posttranscriptional regulation of lipid metabolism by non-coding RNAs and RNA binding proteins. Semin Cell Dev Biol 2018;81:129-40. [PMID: 29183708 DOI: 10.1016/j.semcdb.2017.11.026] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
196 Kang HY, Choi YK, Jeong YI, Choi KC, Hyun SH, Hwang WS, Jeung EB. Immortalization of Porcine 11β-Hydroxysteroid Dehydrogenase Type 1-Transgenic Liver Cells Using SV40 Large T Antigen. Int J Mol Sci 2017;18:E2625. [PMID: 29206210 DOI: 10.3390/ijms18122625] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
197 Wang G, Dong F, Xu Z, Sharma S, Hu X, Chen D, Zhang L, Zhang J, Dong Q. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma. BMC Cancer. 2017;17:805. [PMID: 29191172 DOI: 10.1186/s12885-017-3816-1] [Cited by in Crossref: 53] [Cited by in F6Publishing: 60] [Article Influence: 8.8] [Reference Citation Analysis]
198 Almas I, Afzal S, Idrees M, Ashraf MU, Amin I, Shahid M, Zahid K, Zahid S. Role of circulatory microRNAs in the pathogenesis of hepatitis C virus. Virusdisease. 2017;28:360-367. [PMID: 29291226 DOI: 10.1007/s13337-017-0407-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
199 Feng Z, Qi S, Zhang Y, Qi Z, Yan L, Zhou J, He F, Li Q, Yang Y, Chen Q, Xiao S, Li Q, Chen Y, Zhang Y. Ly6G+ neutrophil-derived miR-223 inhibits the NLRP3 inflammasome in mitochondrial DAMP-induced acute lung injury. Cell Death Dis 2017;8:e3170. [PMID: 29144508 DOI: 10.1038/cddis.2017.549] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 9.8] [Reference Citation Analysis]
200 Hu B, Tang WG, Fan J, Xu Y, Sun HX. Differentially expressed miRNAs in hepatocellular carcinoma cells under hypoxic conditions are associated with transcription and phosphorylation. Oncol Lett 2018;15:467-74. [PMID: 29387230 DOI: 10.3892/ol.2017.7349] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
201 Chai C, Rivkin M, Berkovits L, Simerzin A, Zorde-Khvalevsky E, Rosenberg N, Klein S, Yaish D, Durst R, Shpitzen S, Udi S, Tam J, Heeren J, Worthmann A, Schramm C, Kluwe J, Ravid R, Hornstein E, Giladi H, Galun E. Metabolic Circuit Involving Free Fatty Acids, microRNA 122, and Triglyceride Synthesis in Liver and Muscle Tissues. Gastroenterology 2017;153:1404-15. [PMID: 28802563 DOI: 10.1053/j.gastro.2017.08.013] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 9.5] [Reference Citation Analysis]
202 Quirin KA, Kwon JJ, Alioufi A, Factora T, Temm CJ, Jacobsen M, Sandusky GE, Shontz K, Chicoine LG, Clark KR, Mendell JT, Korc M, Kota J. Safety and Efficacy of AAV Retrograde Pancreatic Ductal Gene Delivery in Normal and Pancreatic Cancer Mice. Mol Ther Methods Clin Dev 2018;8:8-20. [PMID: 29349096 DOI: 10.1016/j.omtm.2017.09.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
203 Chowdhary V, Teng KY, Thakral S, Zhang B, Lin CH, Wani N, Bruschweiler-Li L, Zhang X, James L, Yang D, Junge N, Brüschweiler R, Lee WM, Ghoshal K. miRNA-122 Protects Mice and Human Hepatocytes from Acetaminophen Toxicity by Regulating Cytochrome P450 Family 1 Subfamily A Member 2 and Family 2 Subfamily E Member 1 Expression. Am J Pathol 2017;187:2758-74. [PMID: 28963035 DOI: 10.1016/j.ajpath.2017.08.026] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
204 Kaufmann SHE, Dorhoi A, Hotchkiss RS, Bartenschlager R. Host-directed therapies for bacterial and viral infections. Nat Rev Drug Discov 2018;17:35-56. [PMID: 28935918 DOI: 10.1038/nrd.2017.162] [Cited by in Crossref: 336] [Cited by in F6Publishing: 347] [Article Influence: 56.0] [Reference Citation Analysis]
205 Sebode M, Schulz L, Lohse AW. "Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis. Int J Mol Sci 2017;18:E1954. [PMID: 28895915 DOI: 10.3390/ijms18091954] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
206 Murray DD, Suzuki K, Law M, Trebicka J, Neuhaus Nordwall J, Johnson M, Vjecha MJ, Kelleher AD, Emery S. Circulating miR-122 and miR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individuals. Sci Rep 2017;7:10934. [PMID: 28883647 DOI: 10.1038/s41598-017-11405-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
207 Livingstone MC, Johnson NM, Roebuck BD, Kensler TW, Groopman JD. Profound changes in miRNA expression during cancer initiation by aflatoxin B1 and their abrogation by the chemopreventive triterpenoid CDDO-Im. Mol Carcinog 2017;56:2382-90. [PMID: 28218475 DOI: 10.1002/mc.22635] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
208 Klingenberg M, Matsuda A, Diederichs S, Patel T. Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets. J Hepatol 2017;67:603-18. [PMID: 28438689 DOI: 10.1016/j.jhep.2017.04.009] [Cited by in Crossref: 230] [Cited by in F6Publishing: 247] [Article Influence: 38.3] [Reference Citation Analysis]
209 Lin K, Ma W, Scharner J, Liu Y, Krainer AR. A human-specific switch of alternatively spliced AFMID isoforms contributes to TP53 mutations and tumor recurrence in hepatocellular carcinoma.. [DOI: 10.1101/169029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
210 Luna JM, Barajas JM, Teng KY, Sun HL, Moore MJ, Rice CM, Darnell RB, Ghoshal K. Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer. Mol Cell 2017;67:400-410.e7. [PMID: 28735896 DOI: 10.1016/j.molcel.2017.06.025] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 7.5] [Reference Citation Analysis]
211 Cheng L, Zhu Y, Han H, Zhang Q, Cui K, Shen H, Zhang J, Yan J, Prochownik E, Li Y. MicroRNA-148a deficiency promotes hepatic lipid metabolism and hepatocarcinogenesis in mice. Cell Death Dis 2017;8:e2916. [PMID: 28703810 DOI: 10.1038/cddis.2017.309] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 6.2] [Reference Citation Analysis]
212 Stelma F, van der Ree MH, Sinnige MJ, Brown A, Swadling L, de Vree JML, Willemse SB, van der Valk M, Grint P, Neben S, Klenerman P, Barnes E, Kootstra NA, Reesink HW. Immune phenotype and function of natural killer and T cells in chronic hepatitis C patients who received a single dose of anti-MicroRNA-122, RG-101. Hepatology 2017;66:57-68. [PMID: 28295463 DOI: 10.1002/hep.29148] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
213 Li M, Tang Y, Wu L, Mo F, Wang X, Li H, Qi R, Zhang H, Srivastava A, Ling C. The hepatocyte-specific HNF4α/miR-122 pathway contributes to iron overload-mediated hepatic inflammation. Blood 2017;130:1041-51. [PMID: 28655781 DOI: 10.1182/blood-2016-12-755967] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 5.5] [Reference Citation Analysis]
214 Dweep H, Morikawa Y, Gong B, Yan J, Liu Z, Chen T, Bisgin H, Zou W, Hong H, Shi T, Gong P, Castro C, Uehara T, Wang Y, Tong W. Mechanistic roles of microRNAs in hepatocarcinogenesis: A study of thioacetamide with multiple doses and time-points of rats. Sci Rep 2017;7:3054. [PMID: 28596526 DOI: 10.1038/s41598-017-02798-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
215 Sun HL, Cui R, Zhou J, Teng KY, Hsiao YH, Nakanishi K, Fassan M, Luo Z, Shi G, Tili E, Kutay H, Lovat F, Vicentini C, Huang HL, Wang SW, Kim T, Zanesi N, Jeon YJ, Lee TJ, Guh JH, Hung MC, Ghoshal K, Teng CM, Peng Y, Croce CM. ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5. Cancer Cell 2016;30:723-36. [PMID: 27846390 DOI: 10.1016/j.ccell.2016.10.001] [Cited by in Crossref: 96] [Cited by in F6Publishing: 97] [Article Influence: 16.0] [Reference Citation Analysis]
216 Lou G, Yang Y, Liu F, Ye B, Chen Z, Zheng M, Liu Y. MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis. J Cell Mol Med. 2017;21:2963-2973. [PMID: 28544786 DOI: 10.1111/jcmm.13208] [Cited by in Crossref: 107] [Cited by in F6Publishing: 115] [Article Influence: 17.8] [Reference Citation Analysis]
217 Gerlach CV, Vaidya VS. MicroRNAs in injury and repair. Arch Toxicol 2017;91:2781-97. [PMID: 28501916 DOI: 10.1007/s00204-017-1974-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
218 Adams RL, Pirakitikulr N, Pyle AM. Functional RNA structures throughout the Hepatitis C Virus genome. Curr Opin Virol 2017;24:79-86. [PMID: 28511116 DOI: 10.1016/j.coviro.2017.04.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
219 Ono C, Fukuhara T, Motooka D, Nakamura S, Okuzaki D, Yamamoto S, Tamura T, Mori H, Sato A, Uemura K, Fauzyah Y, Kurihara T, Suda T, Nishio A, Hmwe SS, Okamoto T, Tatsumi T, Takehara T, Chayama K, Wakita T, Koike K, Matsuura Y. Characterization of miR-122-independent propagation of HCV. PLoS Pathog 2017;13:e1006374. [PMID: 28494029 DOI: 10.1371/journal.ppat.1006374] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
220 Neudecker V, Haneklaus M, Jensen O, Khailova L, Masterson JC, Tye H, Biette K, Jedlicka P, Brodsky KS, Gerich ME, Mack M, Robertson AAB, Cooper MA, Furuta GT, Dinarello CA, O'Neill LA, Eltzschig HK, Masters SL, McNamee EN. Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome. J Exp Med. 2017;214:1737-1752. [PMID: 28487310 DOI: 10.1084/jem.20160462] [Cited by in Crossref: 228] [Cited by in F6Publishing: 237] [Article Influence: 38.0] [Reference Citation Analysis]
221 Shapiro JP, Komar HM, Hancioglu B, Yu L, Jin M, Ogata Y, Hart PA, Cruz-Monserrate Z, Lesinski GB, Conwell DL. Laser Capture Microdissection of Pancreatic Acinar Cells to Identify Proteomic Alterations in a Murine Model of Caerulein-Induced Pancreatitis. Clin Transl Gastroenterol. 2017;8:e89. [PMID: 28406494 DOI: 10.1038/ctg.2017.15] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
222 He B, He Y, Shi W, Gong S, Chen X, Xiao J, Gu J, Ding W, Wang Y. Bioinformatics analysis of gene expression alterations in microRNA‑122 knockout mice with hepatocellular carcinoma. Mol Med Rep 2017;15:3681-9. [PMID: 28393247 DOI: 10.3892/mmr.2017.6445] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
223 Mishra PK, Ying W, Nandi SS, Bandyopadhyay GK, Patel KK, Mahata SK. Diabetic Cardiomyopathy: An Immunometabolic Perspective. Front Endocrinol (Lausanne) 2017;8:72. [PMID: 28439258 DOI: 10.3389/fendo.2017.00072] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 7.8] [Reference Citation Analysis]
224 Zhou L, Hussain MM. Human MicroRNA-548p Decreases Hepatic Apolipoprotein B Secretion and Lipid Synthesis. Arterioscler Thromb Vasc Biol 2017;37:786-93. [PMID: 28336556 DOI: 10.1161/ATVBAHA.117.309247] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
225 Vallabhajosyula P, Korutla L, Habertheuer A, Yu M, Rostami S, Yuan CX, Reddy S, Liu C, Korutla V, Koeberlein B, Trofe-Clark J, Rickels MR, Naji A. Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017;127:1375-1391. [PMID: 28319051 DOI: 10.1172/jci87993] [Cited by in Crossref: 96] [Cited by in F6Publishing: 96] [Article Influence: 16.0] [Reference Citation Analysis]
226 Chelomina GN. Genomics and transcriptomics of the Chinese liver fluke Clonorchis sinensis (Opisthorchiidae, Trematoda). Mol Biol 2017;51:184-193. [DOI: 10.1134/s0026893317020078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
227 de Paula Simino LA, de Fante T, Figueiredo Fontana M, Oliveira Borges F, Torsoni MA, Milanski M, Velloso LA, Souza Torsoni A. Lipid overload during gestation and lactation can independently alter lipid homeostasis in offspring and promote metabolic impairment after new challenge to high-fat diet. Nutr Metab (Lond) 2017;14:16. [PMID: 28239403 DOI: 10.1186/s12986-017-0168-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
228 Koduru SV, Tiwari AK, Leberfinger A, Hazard SW, Kawasawa YI, Mahajan M, Ravnic DJ. A Comprehensive NGS Data Analysis of Differentially Regulated miRNAs, piRNAs, lncRNAs and sn/snoRNAs in Triple Negative Breast Cancer. J Cancer. 2017;8:578-596. [PMID: 28367238 DOI: 10.7150/jca.17633] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
229 Latorre J, Moreno-Navarrete JM, Mercader JM, Sabater M, Rovira Ò, Gironès J, Ricart W, Fernández-Real JM, Ortega FJ. Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD. Int J Obes (Lond) 2017;41:620-30. [PMID: 28119530 DOI: 10.1038/ijo.2017.21] [Cited by in Crossref: 74] [Cited by in F6Publishing: 78] [Article Influence: 12.3] [Reference Citation Analysis]
230 de Paula Simino LA, Torsoni MA, Torsoni AS. Obesogenic Programming of Foetal Hepatic Metabolism by microRNAs. Diet, Nutrition, and Fetal Programming 2017. [DOI: 10.1007/978-3-319-60289-9_16] [Reference Citation Analysis]
231 Echeverría N, Moreno P, Cristina J. Molecular Evolution of Hepatitis C Virus: From Epidemiology to Antiviral Therapy (Current Research in Latin America). Human Virology in Latin America 2017. [DOI: 10.1007/978-3-319-54567-7_17] [Reference Citation Analysis]
232 Mann J. Epigenetics in Liver Disease. Liver Pathophysiology 2017. [DOI: 10.1016/b978-0-12-804274-8.00015-1] [Reference Citation Analysis]
233 Madison B, Kerr T. MicroRNAs in the Pathogenesis, Diagnosis, and Treatment of Liver Disease. Translating MicroRNAs to the Clinic 2017. [DOI: 10.1016/b978-0-12-800553-8.00004-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
234 Ait-ahmed Y, Lafdil F. Impact of Cytokines in Hepatocellular Carcinoma Initiation and Progression. Immunotherapy of Hepatocellular Carcinoma 2017. [DOI: 10.1007/978-3-319-64958-0_9] [Reference Citation Analysis]
235 Song G, Vollbrecht H. Clinical Application of MicroRNAs in Liver Diseases. Translating MicroRNAs to the Clinic 2017. [DOI: 10.1016/b978-0-12-800553-8.00005-6] [Reference Citation Analysis]
236 Murakami Y, Kawada N. MicroRNAs in hepatic pathophysiology. Hepatol Res 2017;47:60-9. [PMID: 27101519 DOI: 10.1111/hepr.12730] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 7.3] [Reference Citation Analysis]
237 Sanjay S, Girish C. Role of miRNA and its potential as a novel diagnostic biomarker in drug-induced liver injury. Eur J Clin Pharmacol 2017;73:399-407. [PMID: 28028586 DOI: 10.1007/s00228-016-2183-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
238 Robertson KA, Ghazal P. Interferon Control of the Sterol Metabolic Network: Bidirectional Molecular Circuitry-Mediating Host Protection. Front Immunol 2016;7:634. [PMID: 28066443 DOI: 10.3389/fimmu.2016.00634] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
239 Banini BA, Sanyal AJ. Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options. Clin Med Insights Ther 2016;8:75-84. [PMID: 28670148 DOI: 10.4137/cmt.s18885] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
240 Teng KY, Han J, Zhang X, Hsu SH, He S, Wani NA, Barajas JM, Snyder LA, Frankel WL, Caligiuri MA, Jacob ST, Yu J, Ghoshal K. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model. Mol Cancer Ther 2017;16:312-22. [PMID: 27980102 DOI: 10.1158/1535-7163.MCT-16-0124] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 10.4] [Reference Citation Analysis]
241 Alrob OA, Khatib S, Naser SA. MicroRNAs 33, 122, and 208: a potential novel targets in the treatment of obesity, diabetes, and heart-related diseases. J Physiol Biochem 2017;73:307-14. [PMID: 27966196 DOI: 10.1007/s13105-016-0543-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
242 Itami S, Eguchi Y, Mizutani T, Aoki E, Ohgi T, Kuroda M, Ochiya T, Kato N, Suzuki HI, Kawada N, Murakami Y. Control of HCV Replication With iMIRs, a Novel Anti-RNAi Agent. Mol Ther Nucleic Acids 2015;4:e219. [PMID: 28110745 DOI: 10.1038/mtna.2014.71] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
243 Raitoharju E, Seppälä I, Lyytikäinen LP, Viikari J, Ala-Korpela M, Soininen P, Kangas AJ, Waldenberger M, Klopp N, Illig T, Leiviskä J, Loo BM, Oksala N, Kähönen M, Hutri-Kähönen N, Laaksonen R, Raitakari O, Lehtimäki T. Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism-The Young Finns Study. Sci Rep 2016;6:38262. [PMID: 27917915 DOI: 10.1038/srep38262] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 7.1] [Reference Citation Analysis]
244 Lim E, Lim JY, Kim E, Kim YS, Shin JH, Seok PR, Jung S, Yoo SH, Kim Y. Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice. Nutrients 2016;8:E791. [PMID: 27929393 DOI: 10.3390/nu8120791] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
245 Liu X, Zhao J, Liu Q, Xiong X, Zhang Z, Jiao Y, Li X, Liu B, Li Y, Lu Y. MicroRNA-124 promotes hepatic triglyceride accumulation through targeting tribbles homolog 3. Sci Rep. 2016;6:37170. [PMID: 27845424 DOI: 10.1038/srep37170] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
246 Rivkin M, Simerzin A, Zorde-Khvalevsky E, Chai C, Yuval JB, Rosenberg N, Harari-Steinfeld R, Schneider R, Amir G, Condiotti R, Heikenwalder M, Weber A, Schramm C, Wege H, Kluwe J, Galun E, Giladi H. Inflammation-Induced Expression and Secretion of MicroRNA 122 Leads to Reduced Blood Levels of Kidney-Derived Erythropoietin and Anemia. Gastroenterology 2016;151:999-1010.e3. [PMID: 27477940 DOI: 10.1053/j.gastro.2016.07.031] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 6.0] [Reference Citation Analysis]
247 Hartling HJ, Ballegaard VC, Nielsen NS, Gaardbo JC, Nielsen SD. Immune regulation in chronic hepatitis C virus infection. Scand J Gastroenterol 2016;51:1387-97. [PMID: 27436030 DOI: 10.3109/00365521.2016.1170875] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
248 Simerzin A, Zorde-Khvalevsky E, Rivkin M, Adar R, Zucman-Rossi J, Couchy G, Roskams T, Govaere O, Oren M, Giladi H, Galun E. The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitry. Hepatology 2016;64:1623-36. [PMID: 27302319 DOI: 10.1002/hep.28679] [Cited by in Crossref: 37] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
249 Hardy T, Mann DA. Epigenetics in liver disease: from biology to therapeutics. Gut 2016;65:1895-905. [PMID: 27624887 DOI: 10.1136/gutjnl-2015-311292] [Cited by in Crossref: 95] [Cited by in F6Publishing: 95] [Article Influence: 13.6] [Reference Citation Analysis]
250 Giordano S. miRs*: Innocent bystanders only? Hepatology 2016;64:1424-6. [PMID: 27480463 DOI: 10.1002/hep.28749] [Reference Citation Analysis]
251 Housden BE, Muhar M, Gemberling M, Gersbach CA, Stainier DY, Seydoux G, Mohr SE, Zuber J, Perrimon N. Loss-of-function genetic tools for animal models: cross-species and cross-platform differences. Nat Rev Genet 2017;18:24-40. [PMID: 27795562 DOI: 10.1038/nrg.2016.118] [Cited by in Crossref: 123] [Cited by in F6Publishing: 125] [Article Influence: 17.6] [Reference Citation Analysis]
252 Appourchaux K, Dokmak S, Resche-Rigon M, Treton X, Lapalus M, Gattolliat CH, Porchet E, Martinot-Peignoux M, Boyer N, Vidaud M, Bedossa P, Marcellin P, Bièche I, Estrabaud E, Asselah T. MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C. Sci Rep 2016;6:34935. [PMID: 27731343 DOI: 10.1038/srep34935] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
253 Jones Buie JN, Goodwin AJ, Cook JA, Halushka PV, Fan H. The role of miRNAs in cardiovascular disease risk factors. Atherosclerosis 2016;254:271-81. [PMID: 27693002 DOI: 10.1016/j.atherosclerosis.2016.09.067] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
254 Song K, Kwon H, Han C, Zhang J, Dash S, Lim K, Wu T. Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122. Oncotarget 2015;6:40822-35. [PMID: 26506419 DOI: 10.18632/oncotarget.5812] [Cited by in Crossref: 70] [Cited by in F6Publishing: 75] [Article Influence: 10.0] [Reference Citation Analysis]
255 Dong J, Liang YZ, Zhang J, Wu LJ, Wang S, Hua Q, Yan YX. Potential Role of Lipometabolism-Related MicroRNAs in Peripheral Blood Mononuclear Cells as Biomarkers for Coronary Artery Disease. J Atheroscler Thromb 2017;24:430-41. [PMID: 27629254 DOI: 10.5551/jat.35923] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
256 Senís E, Mockenhaupt S, Rupp D, Bauer T, Paramasivam N, Knapp B, Gronych J, Grosse S, Windisch MP, Schmidt F, Theis FJ, Eils R, Lichter P, Schlesner M, Bartenschlager R, Grimm D. TALEN/CRISPR-mediated engineering of a promoterless anti-viral RNAi hairpin into an endogenous miRNA locus. Nucleic Acids Res 2017;45:e3. [PMID: 27614072 DOI: 10.1093/nar/gkw805] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
257 Tian Y, Mok MT, Yang P, Cheng AS. Epigenetic Activation of Wnt/β-Catenin Signaling in NAFLD-Associated Hepatocarcinogenesis. Cancers (Basel) 2016;8:E76. [PMID: 27556491 DOI: 10.3390/cancers8080076] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
258 Azevedo-Pouly AC, Sutaria DS, Jiang J, Elgamal OA, Amari F, Allard D, Grippo PJ, Coppola V, Schmittgen TD. miR-216 and miR-217 expression is reduced in transgenic mouse models of pancreatic adenocarcinoma, knockout of miR-216/miR-217 host gene is embryonic lethal. Funct Integr Genomics 2017;17:203-12. [PMID: 27541609 DOI: 10.1007/s10142-016-0512-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
259 He L, Tian DA, Li PY, He XX. Mouse models of liver cancer: Progress and recommendations. Oncotarget 2015;6:23306-22. [PMID: 26259234 DOI: 10.18632/oncotarget.4202] [Cited by in Crossref: 64] [Cited by in F6Publishing: 73] [Article Influence: 9.1] [Reference Citation Analysis]
260 Beltrán-Anaya FO, Cedro-Tanda A, Hidalgo-Miranda A, Romero-Cordoba SL. Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism. Front Physiol 2016;7:342. [PMID: 27551267 DOI: 10.3389/fphys.2016.00342] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
261 Shirvani-Dastgerdi E, Schwartz RE, Ploss A. Hepatocarcinogenesis associated with hepatitis B, delta and C viruses. Curr Opin Virol 2016;20:1-10. [PMID: 27504999 DOI: 10.1016/j.coviro.2016.07.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
262 Hsu SH, Delgado ER, Otero PA, Teng KY, Kutay H, Meehan KM, Moroney JB, Monga JK, Hand NJ, Friedman JR, Ghoshal K, Duncan AW. MicroRNA-122 regulates polyploidization in the murine liver. Hepatology 2016;64:599-615. [PMID: 27016325 DOI: 10.1002/hep.28573] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 8.7] [Reference Citation Analysis]
263 Matsuda A, Yan IK, Foye C, Parasramka M, Patel T. MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases. Best Pract Res Clin Endocrinol Metab 2016;30:577-90. [PMID: 27923452 DOI: 10.1016/j.beem.2016.07.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
264 Graffmann N, Ring S, Kawala MA, Wruck W, Ncube A, Trompeter HI, Adjaye J. Modeling Nonalcoholic Fatty Liver Disease with Human Pluripotent Stem Cell-Derived Immature Hepatocyte-Like Cells Reveals Activation of PLIN2 and Confirms Regulatory Functions of Peroxisome Proliferator-Activated Receptor Alpha. Stem Cells Dev. 2016;25:1119-1133. [PMID: 27308945 DOI: 10.1089/scd.2015.0383] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 9.4] [Reference Citation Analysis]
265 Chauhan R, Lahiri N. Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma. Biomark Cancer. 2016;8:37-55. [PMID: 27398029 DOI: 10.4137/bic.s34413] [Cited by in Crossref: 34] [Cited by in F6Publishing: 60] [Article Influence: 4.9] [Reference Citation Analysis]
266 Kim GW, Lee SH, Cho H, Kim M, Shin EC, Oh JW. Hepatitis C Virus Core Protein Promotes miR-122 Destabilization by Inhibiting GLD-2. PLoS Pathog 2016;12:e1005714. [PMID: 27366906 DOI: 10.1371/journal.ppat.1005714] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
267 Yang YM, Lee CG, Koo JH, Kim TH, Lee JM, An J, Kim KM, Kim SG. Gα12 overexpressed in hepatocellular carcinoma reduces microRNA-122 expression via HNF4α inactivation, which causes c-Met induction. Oncotarget 2015;6:19055-69. [PMID: 25965999 DOI: 10.18632/oncotarget.3957] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
268 He J, Wang W, Lu L, Tian Y, Niu D, Ren J, Dong L, Sun S, Zhao Y, Chen L, Shen J, Li X. Analysis of miRNAs and their target genes associated with lipid metabolism in duck liver. Sci Rep 2016;6:27418. [PMID: 27272010 DOI: 10.1038/srep27418] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
269 Neudecker V, Brodsky KS, Kreth S, Ginde AA, Eltzschig HK. Emerging Roles for MicroRNAs in Perioperative Medicine. Anesthesiology 2016;124:489-506. [PMID: 26632665 DOI: 10.1097/ALN.0000000000000969] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 6.9] [Reference Citation Analysis]
270 Otsuka M, Kishikawa T, Yoshikawa T, Yamagami M, Ohno M, Takata A, Shibata C, Ishibashi R, Koike K. MicroRNAs and liver disease. J Hum Genet. 2017;62:75-80. [PMID: 27225852 DOI: 10.1038/jhg.2016.53] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 6.1] [Reference Citation Analysis]
271 Kishikawa T, Otsuka M, Tan PS, Ohno M, Sun X, Yoshikawa T, Shibata C, Takata A, Kojima K, Takehana K, Ohishi M, Ota S, Noyama T, Kondo Y, Sato M, Soga T, Hoshida Y, Koike K. Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine. Oncotarget 2015;6:8339-52. [PMID: 25826076 DOI: 10.18632/oncotarget.3234] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
272 Novák J, Olejníčková V, Tkáčová N, Santulli G. Mechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis. Adv Exp Med Biol 2015;887:79-100. [PMID: 26662987 DOI: 10.1007/978-3-319-22380-3_5] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 10.6] [Reference Citation Analysis]
273 Szabo G, Csak T. Role of MicroRNAs in NAFLD/NASH. Dig Dis Sci 2016;61:1314-24. [PMID: 26769057 DOI: 10.1007/s10620-015-4002-4] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 9.1] [Reference Citation Analysis]
274 Adlakha YK, Saini N. MicroRNA: a connecting road between apoptosis and cholesterol metabolism. Tumour Biol 2016;37:8529-54. [PMID: 27105614 DOI: 10.1007/s13277-016-4988-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
275 Willeit P, Skroblin P, Kiechl S, Fernández-Hernando C, Mayr M. Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease? Eur Heart J 2016;37:3260-6. [PMID: 27099265 DOI: 10.1093/eurheartj/ehw146] [Cited by in Crossref: 78] [Cited by in F6Publishing: 84] [Article Influence: 11.1] [Reference Citation Analysis]
276 Valdmanis PN, Gu S, Chu K, Jin L, Zhang F, Munding EM, Zhang Y, Huang Y, Kutay H, Ghoshal K, Lisowski L, Kay MA. RNA interference-induced hepatotoxicity results from loss of the first synthesized isoform of microRNA-122 in mice. Nat Med 2016;22:557-62. [PMID: 27064447 DOI: 10.1038/nm.4079] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
277 Zeng C, Wang YL, Xie C, Sang Y, Li TJ, Zhang M, Wang R, Zhang Q, Zheng L, Zhuang SM. Identification of a novel TGF-β-miR-122-fibronectin 1/serum response factor signaling cascade and its implication in hepatic fibrogenesis. Oncotarget 2015;6:12224-33. [PMID: 25909171 DOI: 10.18632/oncotarget.3652] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 7.1] [Reference Citation Analysis]
278 Zilbauer M, Zellos A, Heuschkel R, Gasparetto M, Kraiczy J, Postberg J, Greco L, Auricchio R, Galatola M, Embleton N, Wirth S, Jenke A. Epigenetics in Paediatric Gastroenterology, Hepatology, and Nutrition: Present Trends and Future Perspectives. J Pediatr Gastroenterol Nutr 2016;62:521-9. [PMID: 26628441 DOI: 10.1097/MPG.0000000000001053] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
279 Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol 2016;64:S84-S101. [PMID: 27084040 DOI: 10.1016/j.jhep.2016.02.021] [Cited by in Crossref: 461] [Cited by in F6Publishing: 477] [Article Influence: 65.9] [Reference Citation Analysis]
280 Meng X, Guo J, Fang W, Dou L, Li M, Huang X, Zhou S, Man Y, Tang W, Yu L, Li J. Liver MicroRNA-291b-3p Promotes Hepatic Lipogenesis through Negative Regulation of Adenosine 5'-Monophosphate (AMP)-activated Protein Kinase α1. J Biol Chem 2016;291:10625-34. [PMID: 27013659 DOI: 10.1074/jbc.M116.713768] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
281 Yin S, Fan Y, Zhang H, Zhao Z, Hao Y, Li J, Sun C, Yang J, Yang Z, Yang X, Lu J, Xi JJ. Differential TGFβ pathway targeting by miR-122 in humans and mice affects liver cancer metastasis. Nat Commun 2016;7:11012. [PMID: 26987776 DOI: 10.1038/ncomms11012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
282 Goedeke L, Wagschal A, Fernández-Hernando C, Näär AM. miRNA regulation of LDL-cholesterol metabolism. Biochim Biophys Acta 2016;1861:2047-52. [PMID: 26968099 DOI: 10.1016/j.bbalip.2016.03.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
283 Afonso MB, Rodrigues PM, Simão AL, Castro RE. Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma. J Clin Med 2016;5:E30. [PMID: 26950158 DOI: 10.3390/jcm5030030] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 8.7] [Reference Citation Analysis]
284 Tamori A, Murakami Y, Kubo S, Itami S, Uchida-Kobayashi S, Morikawa H, Enomoto M, Takemura S, Tanahashi T, Taguchi YH, Kawada N. MicroRNA expression in hepatocellular carcinoma after the eradication of chronic hepatitis virus C infection using interferon therapy. Hepatol Res 2016;46:E26-35. [PMID: 25788219 DOI: 10.1111/hepr.12518] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
285 Mizuguchi Y, Takizawa T, Yoshida H, Uchida E. Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review. Hepatol Res 2016;46:391-406. [PMID: 26490438 DOI: 10.1111/hepr.12606] [Cited by in Crossref: 77] [Cited by in F6Publishing: 85] [Article Influence: 11.0] [Reference Citation Analysis]
286 Ambade A, Satishchandran A, Szabo G. Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1α activation. Sci Rep 2016;6:21340. [PMID: 26888602 DOI: 10.1038/srep21340] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 7.1] [Reference Citation Analysis]
287 Teng KY, Ghoshal K. Role of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver Fibrosis. Gene Expr 2015;16:155-62. [PMID: 26637395 DOI: 10.3727/105221615X14399878166078] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
288 Baldán Á, de Aguiar Vallim TQ. miRNAs and High-Density Lipoprotein metabolism. Biochim Biophys Acta 2016;1861:2053-61. [PMID: 26869447 DOI: 10.1016/j.bbalip.2016.01.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
289 Liang HW, Wang N, Wang Y, Wang F, Fu Z, Yan X, Zhu H, Diao W, Ding Y, Chen X, Zhang CY, Zen K. Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122. J Hepatol 2016;64:278-91. [PMID: 26409216 DOI: 10.1016/j.jhep.2015.09.013] [Cited by in Crossref: 85] [Cited by in F6Publishing: 86] [Article Influence: 12.1] [Reference Citation Analysis]
290 Luna JM, Michailidis E, Rice CM. Mopping up miRNA: An integrated HBV transcript disrupts liver homeostasis by sequestering miR-122. J Hepatol 2016;64:257-9. [PMID: 26541590 DOI: 10.1016/j.jhep.2015.10.023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
291 Thurnherr T, Mah WC, Lei Z, Jin Y, Rozen SG, Lee CG. Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways. Sci Rep 2016;6:20065. [PMID: 26817861 DOI: 10.1038/srep20065] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 6.1] [Reference Citation Analysis]
292 Rotllan N, Price N, Pati P, Goedeke L, Fernández-Hernando C. microRNAs in lipoprotein metabolism and cardiometabolic disorders. Atherosclerosis 2016;246:352-60. [PMID: 26828754 DOI: 10.1016/j.atherosclerosis.2016.01.025] [Cited by in Crossref: 70] [Cited by in F6Publishing: 72] [Article Influence: 10.0] [Reference Citation Analysis]
293 Wang S, Yeh S, Chen P. Hepatocellular Carcinoma and Hepatitis C Virus. Hepatitis C Virus II 2016. [DOI: 10.1007/978-4-431-56101-9_4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
294 Bukong TN, Saha B, Szabo G. HCV, Alcohol, and the Liver. Hepatitis C Virus II 2016. [DOI: 10.1007/978-4-431-56101-9_5] [Reference Citation Analysis]
295 Otsuka M. Inflammation-Associated Carcinogenesis Mediated by the Impairment of microRNA Function in the Gastroenterological Organs. Chronic Inflammation 2016. [DOI: 10.1007/978-4-431-56068-5_18] [Reference Citation Analysis]
296 Bruce KD, Cagampang FR. Developmental Programming of Nonalcoholic Fatty Liver Disease (NAFLD). Parental Obesity: Intergenerational Programming and Consequences 2016. [DOI: 10.1007/978-1-4939-6386-7_12] [Reference Citation Analysis]
297 Brennan E, Mcclelland A, Hagiwara S, Godson C, Kantharidis P. miRNAs in the Pathophysiology of Diabetes and Their Value as Biomarkers. Epigenetic Biomarkers and Diagnostics 2016. [DOI: 10.1016/b978-0-12-801899-6.00031-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
298 Eslam M, George J. Genetic and epigenetic mechanisms of NASH. Hepatol Int 2016;10:394-406. [PMID: 26683320 DOI: 10.1007/s12072-015-9689-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
299 Aboulnasr F, Hazari S, Nayak S, Chandra PK, Panigrahi R, Ferraris P, Chava S, Kurt R, Song K, Dash A, Balart LA, Garry RF, Wu T, Dash S. IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System. PLoS One 2015;10:e0141655. [PMID: 26657215 DOI: 10.1371/journal.pone.0141655] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
300 Gu P, Liu FG, Sun XG, Chen L, Li L, Liu XS. Effect of formaldehyde on miRNA122 and its downstream molecules a disintegrin and metalloproteinase 10 and serum response factor in the liver of mice. Shijie Huaren Xiaohua Zazhi 2015; 23(34): 5435-5442 [DOI: 10.11569/wcjd.v23.i34.5435] [Reference Citation Analysis]
301 Nakamura M, Kanda T, Sasaki R, Haga Y, Jiang X, Wu S, Nakamoto S, Yokosuka O. MicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate Cells. PLoS One. 2015;10:e0144295. [PMID: 26636761 DOI: 10.1371/journal.pone.0144295] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
302 Li X, Lian F, Liu C, Hu KQ, Wang XD. Isocaloric Pair-Fed High-Carbohydrate Diet Induced More Hepatic Steatosis and Inflammation than High-Fat Diet Mediated by miR-34a/SIRT1 Axis in Mice. Sci Rep 2015;5:16774. [PMID: 26608583 DOI: 10.1038/srep16774] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
303 Jin HY, Xiao C. MicroRNA Mechanisms of Action: What have We Learned from Mice? Front Genet 2015;6:328. [PMID: 26635864 DOI: 10.3389/fgene.2015.00328] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
304 Lu W, Zhang Y, Zhou L, Wang X, Mu J, Jiang L, Hu Y, Dong P, Liu Y. miR-122 inhibits cancer cell malignancy by targeting PKM2 in gallbladder carcinoma. Tumour Biol. 2015;. [PMID: 26546436 DOI: 10.1007/s13277-015-4308-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
305 Shlomai A. Hepatitis C virus addiction to liver miR-122 takes its Toll on the host. Hepatology 2015;62:1633-5. [PMID: 26096908 DOI: 10.1002/hep.27947] [Reference Citation Analysis]
306 Marchetti A, Bisceglia F, Cozzolino AM, Tripodi M. New Tools for Molecular Therapy of Hepatocellular Carcinoma. Diseases 2015;3:325-40. [PMID: 28943628 DOI: 10.3390/diseases3040325] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
307 Liu da Z, Jickling GC, Ander BP, Hull H, Zhan X, Cox C, Shroff N, Dykstra-Aiello C, Stamova B, Sharp FR. Elevating microRNA-122 in blood improves outcomes after temporary middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 2016;36:1374-83. [PMID: 26661204 DOI: 10.1177/0271678X15610786] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 7.3] [Reference Citation Analysis]
308 Udoh US, Valcin JA, Gamble KL, Bailey SM. The Molecular Circadian Clock and Alcohol-Induced Liver Injury. Biomolecules 2015;5:2504-37. [PMID: 26473939 DOI: 10.3390/biom5042504] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
309 Wang G, Wang H, Singh S, Zhou P, Yang S, Wang Y, Zhu Z, Zhang J, Chen A, Billiar T, Monga SP, Wang Q. ADAR1 Prevents Liver Injury from Inflammation and Suppresses Interferon Production in Hepatocytes. Am J Pathol 2015;185:3224-37. [PMID: 26453800 DOI: 10.1016/j.ajpath.2015.08.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
310 Gan L, Xiang W, Xie B, Yu L. Molecular mechanisms of fatty liver in obesity. Front Med 2015;9:275-87. [PMID: 26290284 DOI: 10.1007/s11684-015-0410-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
311 Sud N, Taher J, Su Q. MicroRNAs and Noncoding RNAs in Hepatic Lipid and Lipoprotein Metabolism: Potential Therapeutic Targets of Metabolic Disorders. Drug Dev Res 2015;76:318-27. [PMID: 26286650 DOI: 10.1002/ddr.21269] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
312 Nakagawa H. Recent advances in mouse models of obesity- and nonalcoholic steatohepatitis-associated hepatocarcinogenesis. World J Hepatol 2015; 7(17): 2110-2118 [PMID: 26301053 DOI: 10.4254/wjh.v7.i17.2110] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
313 Oliveira KG, Malta FM, Nastri AC, Widman A, Faria PL, Santana RA, Alves VA, Carrilho FJ, Pinho JR. Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3. Med Microbiol Immunol 2016;205:111-7. [PMID: 26272127 DOI: 10.1007/s00430-015-0431-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
314 Ling C, Wang Y, Zhang Y, Ejjigani A, Yin Z, Lu Y, Wang L, Wang M, Li J, Hu Z, Aslanidi GV, Zhong L, Gao G, Srivastava A, Ling C. Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft model. Hum Gene Ther 2014;25:1023-34. [PMID: 25296041 DOI: 10.1089/hum.2014.099] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
315 Kurtz CL, Fannin EE, Toth CL, Pearson DS, Vickers KC, Sethupathy P. Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver. Sci Rep 2015;5:12911. [PMID: 26246194 DOI: 10.1038/srep12911] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 7.1] [Reference Citation Analysis]
316 Menon B, Gulappa T, Menon KM. miR-122 Regulates LH Receptor Expression by Activating Sterol Response Element Binding Protein in Rat Ovaries. Endocrinology 2015;156:3370-80. [PMID: 26125464 DOI: 10.1210/en.2015-1121] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
317 Hammond SM. An overview of microRNAs. Adv Drug Deliv Rev 2015;87:3-14. [PMID: 25979468 DOI: 10.1016/j.addr.2015.05.001] [Cited by in Crossref: 808] [Cited by in F6Publishing: 876] [Article Influence: 101.0] [Reference Citation Analysis]
318 Willebrords J, Pereira IV, Maes M, Crespo Yanguas S, Colle I, Van Den Bossche B, Da Silva TC, de Oliveira CP, Andraus W, Alves VA. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. Prog Lipid Res. 2015;59:106-125. [PMID: 26073454 DOI: 10.1016/j.plipres.2015.05.002] [Cited by in Crossref: 104] [Cited by in F6Publishing: 95] [Article Influence: 13.0] [Reference Citation Analysis]
319 Lu XF, Zhou YJ, Zhang L, Ji HJ, Li L, Shi YJ, Bu H. Loss of Dicer1 impairs hepatocyte survival and leads to chronic inflammation and progenitor cell activation. World J Gastroenterol 2015; 21(21): 6591-6603 [PMID: 26074697 DOI: 10.3748/wjg.v21.i21.6591] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
320 Bartosch B. Piecing together the key players of fibrosis in chronic hepatitis C: what roles do non-hepatic liver resident cell types play? Gut 2015;64:862-3. [PMID: 25200745 DOI: 10.1136/gutjnl-2014-307957] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
321 Lee S, Choi E, Kim SM, Hwang KC. MicroRNAs as mediators of cardiovascular disease: Targets to be manipulated. World J Biol Chem 2015; 6(2): 34-38 [PMID: 26009702 DOI: 10.4331/wjbc.v6.i2.34] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
322 Beger RD, Bhattacharyya S, Yang X, Gill PS, Schnackenberg LK, Sun J, James LP. Translational biomarkers of acetaminophen-induced acute liver injury. Arch Toxicol 2015;89:1497-522. [PMID: 25983262 DOI: 10.1007/s00204-015-1519-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 6.3] [Reference Citation Analysis]
323 Luna JM, Scheel TK, Danino T, Shaw KS, Mele A, Fak JJ, Nishiuchi E, Takacs CN, Catanese MT, de Jong YP, Jacobson IM, Rice CM, Darnell RB. Hepatitis C virus RNA functionally sequesters miR-122. Cell. 2015;160:1099-1110. [PMID: 25768906 DOI: 10.1016/j.cell.2015.02.025] [Cited by in Crossref: 257] [Cited by in F6Publishing: 226] [Article Influence: 32.1] [Reference Citation Analysis]
324 Sendi H, Mehrab-Mohseni M, Foureau DM, Ghosh S, Walling TL, Steuerwald N, Zamor PJ, Kaplan KJ, Jacobs C, Ahrens WA, Russo MW, Clemens MG, Schrum LW, Bonkovsky HL. MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA. Liver Int 2015;35:1315-23. [PMID: 25302477 DOI: 10.1111/liv.12698] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
325 Bantel H, Thum T, Schulze-Osthoff K. Reply: To PMID 24913549. Hepatology 2015;61:1440-1. [PMID: 25130309 DOI: 10.1002/hep.27352] [Reference Citation Analysis]
326 Roderburg C, Benz F, Vargas Cardenas D, Koch A, Janssen J, Vucur M, Gautheron J, Schneider AT, Koppe C, Kreggenwinkel K, Zimmermann HW, Luedde M, Trautwein C, Tacke F, Luedde T. Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases. Liver Int 2015;35:1172-84. [PMID: 25039534 DOI: 10.1111/liv.12627] [Cited by in Crossref: 84] [Cited by in F6Publishing: 85] [Article Influence: 10.5] [Reference Citation Analysis]
327 Antoine DJ, Dear JW, Goldring CE, Park BK. Understanding the pathophysiological regulatory role of microRNAs in acute liver failure. Hepatology 2015;61:1439-40. [PMID: 25088716 DOI: 10.1002/hep.27349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
328 Olive V, Minella AC, He L. Outside the coding genome, mammalian microRNAs confer structural and functional complexity. Sci Signal 2015;8:re2. [PMID: 25783159 DOI: 10.1126/scisignal.2005813] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
329 Yang Z, Cappello T, Wang L. Emerging role of microRNAs in lipid metabolism. Acta Pharm Sin B 2015;5:145-50. [PMID: 26579440 DOI: 10.1016/j.apsb.2015.01.002] [Cited by in Crossref: 109] [Cited by in F6Publishing: 115] [Article Influence: 13.6] [Reference Citation Analysis]
330 Kalla R, Ventham NT, Kennedy NA, Quintana JF, Nimmo ER, Buck AH, Satsangi J. MicroRNAs: new players in IBD. Gut 2015;64:504-17. [PMID: 25475103 DOI: 10.1136/gutjnl-2014-307891] [Cited by in Crossref: 180] [Cited by in F6Publishing: 162] [Article Influence: 22.5] [Reference Citation Analysis]
331 Gerhard GS, DiStefano JK. Micro RNAs in the development of non-alcoholic fatty liver disease. World J Hepatol 2015; 7(2): 226-234 [PMID: 25729477 DOI: 10.4254/wjh.v7.i2.226] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
332 van Rooij E, Kauppinen S. Development of microRNA therapeutics is coming of age. EMBO Mol Med. 2014;6:851-864. [PMID: 24935956 DOI: 10.15252/emmm.201100899] [Cited by in Crossref: 426] [Cited by in F6Publishing: 445] [Article Influence: 53.3] [Reference Citation Analysis]
333 Csak T, Bala S, Lippai D, Satishchandran A, Catalano D, Kodys K, Szabo G. microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis. Liver Int 2015;35:532-41. [PMID: 25040043 DOI: 10.1111/liv.12633] [Cited by in Crossref: 96] [Cited by in F6Publishing: 97] [Article Influence: 12.0] [Reference Citation Analysis]
334 Bandiera S, Pfeffer S, Baumert TF, Zeisel MB. miR-122--a key factor and therapeutic target in liver disease. J Hepatol 2015;62:448-57. [PMID: 25308172 DOI: 10.1016/j.jhep.2014.10.004] [Cited by in Crossref: 391] [Cited by in F6Publishing: 402] [Article Influence: 48.9] [Reference Citation Analysis]
335 Morris NL, Ippolito JA, Curtis BJ, Chen MM, Friedman SL, Hines IN, Haddad GE, Chang SL, Brown LA, Waldschmidt TJ, Mandrekar P, Kovacs EJ, Choudhry MA. Alcohol and inflammatory responses: summary of the 2013 Alcohol and Immunology Research Interest Group (AIRIG) meeting. Alcohol 2015;49:1-6. [PMID: 25468277 DOI: 10.1016/j.alcohol.2014.07.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
336 Szabo G, Satishchandran A. MicroRNAs in alcoholic liver disease. Semin Liver Dis. 2015;35:36-42. [PMID: 25632933 DOI: 10.1055/s-0034- 1397347] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
337 Xie J, Burt DR, Gao G. Adeno-associated virus-mediated microRNA delivery and therapeutics. Semin Liver Dis. 2015;35:81-88. [PMID: 25632938 DOI: 10.1055/s-0034-1397352] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
338 Szabo G, Satishchandran A. MicroRNAs in alcoholic liver disease. Semin Liver Dis 2015;35:36-42. [PMID: 25632933 DOI: 10.1055/s-0034-1397347] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
339 Sedano CD, Sarnow P. Interaction of host cell microRNAs with the HCV RNA genome during infection of liver cells. Semin Liver Dis 2015;35:75-80. [PMID: 25632937 DOI: 10.1055/s-0034-1397351] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
340 Lian JY, Tuo BG. Role of non-coding RNAs in development and progression of hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2015; 23(3): 396-403 [DOI: 10.11569/wcjd.v23.i3.396] [Reference Citation Analysis]
341 Shibata C, Otsuka M, Kishikawa T, Ohno M, Yoshikawa T, Takata A, Koike K. Diagnostic and therapeutic application of noncoding RNAs for hepatocellular carcinoma. World J Hepatol 2015; 7(1): 1-6 [PMID: 25624991 DOI: 10.4254/wjh.v7.i1.1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
342 Hsu SD, Huang HY, Chou CH, Sun YM, Hsu MT, Tsou AP. Integrated analyses to reconstruct microRNA-mediated regulatory networks in mouse liver using high-throughput profiling. BMC Genomics 2015;16 Suppl 2:S12. [PMID: 25707768 DOI: 10.1186/1471-2164-16-S2-S12] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
343 Cai Y, Zhu L, Zhou Y, Liu X, Liu X, Li X, Lang Q, Qiao X, Xu Z. Identification and analysis of differentially-expressed microRNAs in Japanese encephalitis virus-infected PK-15 cells with deep sequencing. Int J Mol Sci 2015;16:2204-19. [PMID: 25608654 DOI: 10.3390/ijms16012204] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
344 Yang N, Ekanem NR, Sakyi CA, Ray SD. Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics. Adv Drug Deliv Rev 2015;81:62-74. [PMID: 25450260 DOI: 10.1016/j.addr.2014.10.029] [Cited by in Crossref: 122] [Cited by in F6Publishing: 125] [Article Influence: 15.3] [Reference Citation Analysis]
345 Chapman CG, Pekow J. The emerging role of miRNAs in inflammatory bowel disease: a review. Therap Adv Gastroenterol. 2015;8:4-22. [PMID: 25553076 DOI: 10.1177/1756283x14547360] [Cited by in Crossref: 108] [Cited by in F6Publishing: 111] [Article Influence: 13.5] [Reference Citation Analysis]
346 Mattis AN, Song G, Hitchner K, Kim RY, Lee AY, Sharma AD, Malato Y, McManus MT, Esau CC, Koller E, Koliwad S, Lim LP, Maher JJ, Raffai RL, Willenbring H. A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liver. Hepatology 2015;61:141-52. [PMID: 25131933 DOI: 10.1002/hep.27379] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 6.1] [Reference Citation Analysis]
347 Israelow B, Mullokandov G, Agudo J, Sourisseau M, Bashir A, Maldonado AY, Dar AC, Brown BD, Evans MJ. Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors. Nat Commun 2014;5:5408. [PMID: 25403145 DOI: 10.1038/ncomms6408] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 6.6] [Reference Citation Analysis]
348 Hoshida Y, Fuchs BC, Bardeesy N, Baumert TF, Chung RT. Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma. J Hepatol 2014;61:S79-90. [PMID: 25443348 DOI: 10.1016/j.jhep.2014.07.010] [Cited by in Crossref: 146] [Cited by in F6Publishing: 147] [Article Influence: 16.2] [Reference Citation Analysis]
349 Nie YQ, Cao J, Zhou YJ, Liang X, Du YL, Wan YJ, Li YY. The effect of miRNA-122 in regulating fat deposition in a cell line model. J Cell Biochem. 2014;115:839-846. [PMID: 24288170 DOI: 10.1002/jcb.24725] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
350 Katsushima F, Takahashi A, Sakamoto N, Kanno Y, Abe K, Ohira H. Expression of micro-RNAs in peripheral blood mononuclear cells from primary biliary cirrhosis patients. Hepatol Res 2014;44:E189-97. [PMID: 23834361 DOI: 10.1111/hepr.12198] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
351 Mann DA. Epigenetics in liver disease. Hepatology 2014;60:1418-25. [PMID: 24633972 DOI: 10.1002/hep.27131] [Cited by in Crossref: 105] [Cited by in F6Publishing: 100] [Article Influence: 11.7] [Reference Citation Analysis]
352 Takaki Y, Saito Y, Takasugi A, Toshimitsu K, Yamada S, Muramatsu T, Kimura M, Sugiyama K, Suzuki H, Arai E. Silencing of microRNA-122 is an early event during hepatocarcinogenesis from non-alcoholic steatohepatitis. Cancer Sci. 2014;105:1254-1260. [PMID: 25117675 DOI: 10.1111/cas.12498] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 6.3] [Reference Citation Analysis]
353 Tan Y, Ge G, Pan T, Wen D, Chen L, Yu X, Zhou X, Gan J. A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus. PLoS One. 2014;9:e107986. [PMID: 25238238 DOI: 10.1371/journal.pone.0107986] [Cited by in Crossref: 114] [Cited by in F6Publishing: 123] [Article Influence: 12.7] [Reference Citation Analysis]
354 Murakami Y, Tanahashi T, Okada R, Toyoda H, Kumada T, Enomoto M, Tamori A, Kawada N, Taguchi YH, Azuma T. Comparison of hepatocellular carcinoma miRNA expression profiling as evaluated by next generation sequencing and microarray. PLoS One. 2014;9:e106314. [PMID: 25215888 DOI: 10.1371/journal.pone.0106314] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 6.2] [Reference Citation Analysis]
355 Niederwieser C, Kohlschmidt J, Volinia S, Whitman SP, Metzeler KH, Eisfeld AK, Maharry K, Yan P, Frankhouser D, Becker H, Schwind S, Carroll AJ, Nicolet D, Mendler JH, Curfman JP, Wu YZ, Baer MR, Powell BL, Kolitz JE, Moore JO, Carter TH, Bundschuh R, Larson RA, Stone RM, Mrózek K, Marcucci G, Bloomfield CD. Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia. Leukemia 2015;29:567-75. [PMID: 25204569 DOI: 10.1038/leu.2014.267] [Cited by in Crossref: 47] [Cited by in F6Publishing: 55] [Article Influence: 5.2] [Reference Citation Analysis]
356 Saludes V, Latorre I, Meyerhans A, Díez J. MicroRNAs in Human Microbial Infections and Disease Outcomes. Nucleic Acids as Molecular Diagnostics 2014. [DOI: 10.1002/9783527672165.ch10] [Reference Citation Analysis]
357 Callegari E, Gramantieri L, Domenicali M, D’Abundo L, Sabbioni S, Negrini M. MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches. Cell Death Differ. 2015;22:46-57. [PMID: 25190143 DOI: 10.1038/cdd.2014.136] [Cited by in Crossref: 101] [Cited by in F6Publishing: 115] [Article Influence: 11.2] [Reference Citation Analysis]
358 Neppl RL, Wang DZ. The myriad essential roles of microRNAs in cardiovascular homeostasis and disease. Genes Dis 2014;1:18-39. [PMID: 25328909 DOI: 10.1016/j.gendis.2014.06.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
359 Lee JH, Friso S, Choi SW. Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition. Nutrients 2014;6:3303-25. [PMID: 25195642 DOI: 10.3390/nu6083303] [Cited by in Crossref: 73] [Cited by in F6Publishing: 75] [Article Influence: 8.1] [Reference Citation Analysis]
360 Han LL, Lv Y, Guo H, Ruan ZP, Nan KJ. Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy. World J Gastroenterol 2014; 20(30): 10249-10261 [PMID: 25132742 DOI: 10.3748/wjg.v20.i30.10249] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
361 Smolle E, Haybaeck J. Non-coding RNAs and lipid metabolism. Int J Mol Sci 2014;15:13494-513. [PMID: 25093715 DOI: 10.3390/ijms150813494] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
362 Gerold G, Pietschmann T. The HCV life cycle: in vitro tissue culture systems and therapeutic targets. Dig Dis 2014;32:525-37. [PMID: 25034285 DOI: 10.1159/000360830] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
363 Wang SC, Lin XL, Li J, Zhang TT, Wang HY, Shi JW, Yang S, Zhao WT, Xie RY, Wei F. MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA. PLoS One. 2014;9:e101330. [PMID: 24992599 DOI: 10.1371/journal.pone.0101330] [Cited by in Crossref: 77] [Cited by in F6Publishing: 87] [Article Influence: 8.6] [Reference Citation Analysis]
364 Goedeke L, Fernández-Hernando C. MicroRNAs: a connection between cholesterol metabolism and neurodegeneration. Neurobiol Dis 2014;72 Pt A:48-53. [PMID: 24907491 DOI: 10.1016/j.nbd.2014.05.034] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
365 Dubin PH, Yuan H, Devine RK, Hynan LS, Jain MK, Lee WM; Acute Liver Failure Study Group. Micro-RNA-122 levels in acute liver failure and chronic hepatitis C. J Med Virol. 2014;86:1507-1514. [PMID: 24895202 DOI: 10.1002/jmv.23987] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
366 Li F, Ma N, Zhao R, Wu G, Zhang Y, Qiao Y, Han D, Xu Y, Xiang Y, Yan B, Jin J, Lv G, Wang L, Xu C, Gao X, Luo S. Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-β stimulated HSCs in transgenic mice. J Cell Mol Med 2014;18:966-74. [PMID: 24801603 DOI: 10.1111/jcmm.12293] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
367 Novák J, Bienertová-Vašků J, Kára T, Novák M. MicroRNAs involved in the lipid metabolism and their possible implications for atherosclerosis development and treatment. Mediators Inflamm 2014;2014:275867. [PMID: 24876669 DOI: 10.1155/2014/275867] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
368 Yu B, Wang X, Zhou C, Teng L, Ren W, Yang Z, Shih CH, Wang T, Lee RJ, Tang S, Lee LJ. Insight into mechanisms of cellular uptake of lipid nanoparticles and intracellular release of small RNAs. Pharm Res 2014;31:2685-95. [PMID: 24740244 DOI: 10.1007/s11095-014-1366-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
369 Sugiyama K, Ebinuma H, Nakamoto N, Sakasegawa N, Murakami Y, Chu PS, Usui S, Ishibashi Y, Wakayama Y, Taniki N. Prominent steatosis with hypermetabolism of the cell line permissive for years of infection with hepatitis C virus. PLoS One. 2014;9:e94460. [PMID: 24718268 DOI: 10.1371/journal.pone.0094460] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
370 Hung CH, Chiu YC, Chen CH, Hu TH. MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target. Biomed Res Int. 2014;2014:486407. [PMID: 24800233 DOI: 10.1155/2014/486407] [Cited by in Crossref: 39] [Cited by in F6Publishing: 56] [Article Influence: 4.3] [Reference Citation Analysis]
371 Peng F, Xiao X, Jiang Y, Luo K, Tian Y, Peng M, Zhang M, Xu Y, Gong G. HBx down-regulated Gld2 plays a critical role in HBV-related dysregulation of miR-122. PLoS One. 2014;9:e92998. [PMID: 24667324 DOI: 10.1371/journal.pone.0092998] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
372 Valencia-Quintana R, Sánchez-Alarcón J, Tenorio-Arvide MG, Deng Y, Montiel-González JM, Gómez-Arroyo S, Villalobos-Pietrini R, Cortés-Eslava J, Flores-Márquez AR, Arenas-Huertero F. The microRNAs as potential biomarkers for predicting the onset of aflatoxin exposure in human beings: a review. Front Microbiol 2014;5:102. [PMID: 24672518 DOI: 10.3389/fmicb.2014.00102] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
373 Chen J, Jiang S, Cao Y, Yang Y. Altered miRNAs expression profiles and modulation of immune response genes and proteins during neonatal sepsis. J Clin Immunol 2014;34:340-8. [PMID: 24668300 DOI: 10.1007/s10875-014-0004-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
374 Nakao K, Miyaaki H, Ichikawa T. Antitumor function of microRNA-122 against hepatocellular carcinoma. J Gastroenterol. 2014;49:589-593. [PMID: 24531873 DOI: 10.1007/s00535-014-0932-4] [Cited by in Crossref: 80] [Cited by in F6Publishing: 90] [Article Influence: 8.9] [Reference Citation Analysis]
375 Ohno M, Shibata C, Kishikawa T, Yoshikawa T, Takata A, Kojima K, Akanuma M, Kang YJ, Yoshida H, Otsuka M, Koike K. The flavonoid apigenin improves glucose tolerance through inhibition of microRNA maturation in miRNA103 transgenic mice. Sci Rep 2013;3:2553. [PMID: 23989853 DOI: 10.1038/srep02553] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 6.3] [Reference Citation Analysis]
376 Hu R, Pan W, Fedulov AV, Jester W, Jones MR, Weiss ST, Panettieri RA Jr, Tantisira K, Lu Q. MicroRNA-10a controls airway smooth muscle cell proliferation via direct targeting of the PI3 kinase pathway. FASEB J 2014;28:2347-57. [PMID: 24522205 DOI: 10.1096/fj.13-247247] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 6.3] [Reference Citation Analysis]
377 Wang B, Hsu SH, Wang X, Kutay H, Bid HK, Yu J, Ganju RK, Jacob ST, Yuneva M, Ghoshal K. Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2. Hepatology 2014;59:555-66. [PMID: 24038073 DOI: 10.1002/hep.26712] [Cited by in Crossref: 85] [Cited by in F6Publishing: 86] [Article Influence: 9.4] [Reference Citation Analysis]
378 Azhar S. MicroRNA-122: a new player in the negative regulation of LH receptor expression by the LH receptor mRNA binding protein (LRBP). Endocrinology 2013;154:4439-42. [PMID: 24273230 DOI: 10.1210/en.2013-1897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
379 Mennigen JA, Martyniuk CJ, Seiliez I, Panserat S, Skiba-Cassy S. Metabolic consequences of microRNA-122 inhibition in rainbow trout, Oncorhynchus mykiss. BMC Genomics 2014;15:70. [PMID: 24467738 DOI: 10.1186/1471-2164-15-70] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
380 Shaw A, Cornetta K. Design and Potential of Non-Integrating Lentiviral Vectors. Biomedicines 2014;2:14-35. [PMID: 28548058 DOI: 10.3390/biomedicines2010014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
381 Shlomai A, de Jong YP, Rice CM. Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma. Semin Cancer Biol. 2014;26:78-88. [PMID: 24457013 DOI: 10.1016/j.semcancer.2014.01.004] [Cited by in Crossref: 111] [Cited by in F6Publishing: 99] [Article Influence: 12.3] [Reference Citation Analysis]
382 Ferreira DM, Afonso MB, Rodrigues PM, Simão AL, Pereira DM, Borralho PM, Rodrigues CM, Castro RE. c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver. Mol Cell Biol 2014;34:1100-20. [PMID: 24421392 DOI: 10.1128/MCB.00420-13] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 6.1] [Reference Citation Analysis]
383 Huang S, Xie Y, Yang P, Chen P, Zhang L. HCV core protein-induced down-regulation of microRNA-152 promoted aberrant proliferation by regulating Wnt1 in HepG2 cells. PLoS One. 2014;9:e81730. [PMID: 24416131 DOI: 10.1371/journal.pone.0081730] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 5.4] [Reference Citation Analysis]
384 Thirion M, Kanda T, Murakami Y, Ochiya T, Iizasa H. MicroRNAs and Oncogenic Human Viruses. MicroRNAs: Key Regulators of Oncogenesis 2014. [DOI: 10.1007/978-3-319-03725-7_7] [Reference Citation Analysis]
385 de Jong YP, Jacobson IM. Antisense therapy for hepatitis C virus infection. J Hepatol 2014;60:227-8. [PMID: 24036232 DOI: 10.1016/j.jhep.2013.08.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
386 Marquardt JU, Galle PR. MicroRNAs as Novel Targets in Liver Cancer: Facing the Clinical Challenge. MicroRNA Targeted Cancer Therapy 2014. [DOI: 10.1007/978-3-319-05134-5_9] [Reference Citation Analysis]
387 Wittmann J. MicroRNAs and Clinical Implications in Cancer. MicroRNAs: Key Regulators of Oncogenesis 2014. [DOI: 10.1007/978-3-319-03725-7_13] [Reference Citation Analysis]
388 Sun L, He X, Cao Y, Gao P, Zhang H. MicroRNAs and Energy Metabolism in Cancer Cells. MicroRNAs: Key Regulators of Oncogenesis 2014. [DOI: 10.1007/978-3-319-03725-7_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
389 Shibata C, Otsuka M, Kishikawa T, Yoshikawa T, Ohno M, Takata A, Koike K. Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma. Molecular and Cellular Therapies. 2013;1:5. [PMID: 26056570 DOI: 10.1186/2052-8426-1-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
390 Vickers KC, Rye KA, Tabet F. MicroRNAs in the onset and development of cardiovascular disease. Clin Sci (Lond). 2014;126:183-194. [PMID: 24102098 DOI: 10.1042/cs20130203] [Cited by in Crossref: 77] [Cited by in F6Publishing: 83] [Article Influence: 7.7] [Reference Citation Analysis]
391 Zeybel M, Mann DA, Mann J. Epigenetic modifications as new targets for liver disease therapies. J Hepatol 2013;59:1349-53. [PMID: 23747756 DOI: 10.1016/j.jhep.2013.05.039] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
392 Otsuka M, Kishikawa T, Yoshikawa T, Ohno M, Takata A, Shibata C, Koike K. The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects. J Gastroenterol. 2014;49:173-184. [PMID: 24258409 DOI: 10.1007/s00535-013-0909-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
393 Ali N, Allam H, Bader T, May R, Basalingappa KM, Berry WL, Chandrakesan P, Qu D, Weygant N, Bronze MS. Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism. PLoS One. 2013;8:e80304. [PMID: 24260365 DOI: 10.1371/journal.pone.0080304] [Cited by in Crossref: 20] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
394 Nassirpour R, Mehta PP, Yin MJ. miR-122 regulates tumorigenesis in hepatocellular carcinoma by targeting AKT3. PLoS One 2013;8:e79655. [PMID: 24244539 DOI: 10.1371/journal.pone.0079655] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 6.4] [Reference Citation Analysis]
395 Song K, Han C, Zhang J, Lu D, Dash S, Feitelson M, Lim K, Wu T. Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells. Hepatology 2013;58:1681-92. [PMID: 23703729 DOI: 10.1002/hep.26514] [Cited by in Crossref: 97] [Cited by in F6Publishing: 107] [Article Influence: 9.7] [Reference Citation Analysis]
396 Baselga-Escudero L, Blade C, Ribas-Latre A, Casanova E, Suárez M, Torres JL, Salvadó MJ, Arola L, Arola-Arnal A. Resveratrol and EGCG bind directly and distinctively to miR-33a and miR-122 and modulate divergently their levels in hepatic cells. Nucleic Acids Res 2014;42:882-92. [PMID: 24165878 DOI: 10.1093/nar/gkt1011] [Cited by in Crossref: 80] [Cited by in F6Publishing: 81] [Article Influence: 8.0] [Reference Citation Analysis]
397 Spaniel C, Honda M, Selitsky SR, Yamane D, Shimakami T, Kaneko S, Lanford RE, Lemon SM. microRNA-122 abundance in hepatocellular carcinoma and non-tumor liver tissue from Japanese patients with persistent HCV versus HBV infection. PLoS One. 2013;8:e76867. [PMID: 24130799 DOI: 10.1371/journal.pone.0076867] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
398 Hsu SH, Wang B, Kutay H, Bid H, Shreve J, Zhang X, Costinean S, Bratasz A, Houghton P, Ghoshal K. Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure. Am J Pathol 2013;183:1719-30. [PMID: 24113455 DOI: 10.1016/j.ajpath.2013.08.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
399 Wang X, Yu B, Ren W, Mo X, Zhou C, He H, Jia H, Wang L, Jacob ST, Lee RJ, Ghoshal K, Lee LJ. Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations. J Control Release 2013;172:690-8. [PMID: 24121065 DOI: 10.1016/j.jconrel.2013.09.027] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 5.5] [Reference Citation Analysis]
400 Gerold G, Pietschmann T. Opportunities and Risks of Host-targeting Antiviral Strategies for Hepatitis C. Curr Hepat Rep 2013;12:200-13. [PMID: 32214912 DOI: 10.1007/s11901-013-0187-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
401 Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol. 2014;9:287-314. [PMID: 24079833 DOI: 10.1146/annurev-pathol- 012513-104715] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
402 Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol. 2014;9:287-314. [PMID: 24079833 DOI: 10.1146/annurev-pathol-012513-104715] [Cited by in Crossref: 1119] [Cited by in F6Publishing: 1213] [Article Influence: 111.9] [Reference Citation Analysis]
403 Scheel TK, Rice CM. Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nat Med 2013;19:837-49. [PMID: 23836234 DOI: 10.1038/nm.3248] [Cited by in Crossref: 416] [Cited by in F6Publishing: 440] [Article Influence: 41.6] [Reference Citation Analysis]
404 Callegari E, Elamin BK, Sabbioni S, Gramantieri L, Negrini M. Role of microRNAs in hepatocellular carcinoma: a clinical perspective. Onco Targets Ther. 2013;6:1167-1178. [PMID: 24039437 DOI: 10.2147/ott.s36161] [Cited by in Crossref: 19] [Cited by in F6Publishing: 37] [Article Influence: 1.9] [Reference Citation Analysis]
405 Szabo G, Bala S. MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol 2013;10:542-52. [PMID: 23689081 DOI: 10.1038/nrgastro.2013.87] [Cited by in Crossref: 428] [Cited by in F6Publishing: 436] [Article Influence: 42.8] [Reference Citation Analysis]
406 Shukla U, Tumma N, Gratsch T, Dombkowski A, Novak RF. Insights into insulin-mediated regulation of CYP2E1: miR-132/-212 targeting of CYP2E1 and role of phosphatidylinositol 3-kinase, Akt (protein kinase B), mammalian target of rapamycin signaling in regulating miR-132/-212 and miR-122/-181a expression in primary cultured rat hepatocytes. Drug Metab Dispos. 2013;41:1769-1777. [PMID: 23920219 DOI: 10.1124/dmd.113.052860] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
407 Meiliana A, Wijaya A. MicroRNAs in Cardiometabolic Diseases. Indones Biomed J 2013;5:67. [DOI: 10.18585/inabj.v5i2.55] [Reference Citation Analysis]
408 Baselga-Escudero L, Arola-Arnal A, Pascual-Serrano A, Ribas-Latre A, Casanova E, Salvadó MJ, Arola L, Blade C. Chronic administration of proanthocyanidins or docosahexaenoic acid reverses the increase of miR-33a and miR-122 in dyslipidemic obese rats. PLoS One 2013;8:e69817. [PMID: 23922812 DOI: 10.1371/journal.pone.0069817] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]
409 Aranda JF, Madrigal-Matute J, Rotllan N, Fernández-Hernando C. MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases. Free Radic Biol Med. 2013;64:31-39. [PMID: 23871755 DOI: 10.1016/j.freeradbiomed.2013.07.014] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 5.1] [Reference Citation Analysis]
410 Wijnen WJ, Pinto YM, Creemers EE. The therapeutic potential of miRNAs in cardiac fibrosis: where do we stand? J Cardiovasc Transl Res 2013;6:899-908. [PMID: 23821466 DOI: 10.1007/s12265-013-9483-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
411 Sun K, Lai EC. Adult-specific functions of animal microRNAs. Nat Rev Genet. 2013;14:535-548. [PMID: 23817310 DOI: 10.1038/nrg3471] [Cited by in Crossref: 255] [Cited by in F6Publishing: 267] [Article Influence: 25.5] [Reference Citation Analysis]
412 Mao Y, Mohan R, Zhang S, Tang X. MicroRNAs as pharmacological targets in diabetes. Pharmacol Res 2013;75:37-47. [PMID: 23810798 DOI: 10.1016/j.phrs.2013.06.005] [Cited by in Crossref: 56] [Cited by in F6Publishing: 63] [Article Influence: 5.6] [Reference Citation Analysis]
413 Ameres SL, Zamore PD. Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol. 2013;14:475-488. [PMID: 23800994 DOI: 10.1038/nrm3611] [Cited by in Crossref: 865] [Cited by in F6Publishing: 898] [Article Influence: 86.5] [Reference Citation Analysis]
414 Bartenschlager R, Lohmann V, Penin F. The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection. Nat Rev Microbiol. 2013;11:482-496. [PMID: 23748342 DOI: 10.1038/nrmicro3046] [Cited by in Crossref: 287] [Cited by in F6Publishing: 299] [Article Influence: 28.7] [Reference Citation Analysis]
415 Hsu SH, Yu B, Wang X, Lu Y, Schmidt CR, Lee RJ, Lee LJ, Jacob ST, Ghoshal K. Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor. Nanomedicine 2013;9:1169-80. [PMID: 23727126 DOI: 10.1016/j.nano.2013.05.007] [Cited by in Crossref: 100] [Cited by in F6Publishing: 104] [Article Influence: 10.0] [Reference Citation Analysis]
416 Felmlee DJ, Hafirassou ML, Lefevre M, Baumert TF, Schuster C. Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease. Viruses. 2013;5:1292-1324. [PMID: 23698400 DOI: 10.3390/v5051292] [Cited by in Crossref: 102] [Cited by in F6Publishing: 108] [Article Influence: 10.2] [Reference Citation Analysis]
417 Chai S, Ma S. Clinical implications of microRNAs in liver cancer stem cells. Chin J Cancer 2013;32:419-26. [PMID: 23668930 DOI: 10.5732/cjc.013.10038] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
418 Alexander J, Torbenson M, Wu TT, Yeh MM. Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study. J Gastroenterol Hepatol 2013;28:848-54. [PMID: 23302015 DOI: 10.1111/jgh.12116] [Cited by in Crossref: 87] [Cited by in F6Publishing: 89] [Article Influence: 8.7] [Reference Citation Analysis]
419 Su TH, Liu CH, Liu CJ, Chen CL, Ting TT, Tseng TC, Chen PJ, Kao JH, Chen DS. Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C. Proc Natl Acad Sci USA. 2013;110:7844-7849. [PMID: 23613588 DOI: 10.1073/pnas.1306138110] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 5.2] [Reference Citation Analysis]
420 Ceccarelli S, Panera N, Gnani D, Nobili V. Dual Role of MicroRNAs in NAFLD. Int J Mol Sci. 2013;14:8437-8455. [PMID: 23594995 DOI: 10.3390/ijms14048437] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
421 Zeisel MB, Pfeffer S, Baumert TF. miR-122 acts as a tumor suppressor in hepatocarcinogenesis in vivo. J Hepatol 2013;58:821-3. [PMID: 23085250 DOI: 10.1016/j.jhep.2012.10.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
422 Arzumanyan A, Reis HM, Feitelson MA. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat Rev Cancer. 2013;13:123-135. [PMID: 23344543 DOI: 10.1038/nrc3449] [Cited by in Crossref: 556] [Cited by in F6Publishing: 593] [Article Influence: 55.6] [Reference Citation Analysis]
423 Sethupathy P. Needles in the genetic haystack of lipid disorders: single nucleotide polymorphisms in the microRNA regulome. J Lipid Res 2013;54:1168-73. [PMID: 23505316 DOI: 10.1194/jlr.R035766] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
424 Vickers KC, Sethupathy P, Baran-Gale J, Remaley AT. Complexity of microRNA function and the role of isomiRs in lipid homeostasis. J Lipid Res 2013;54:1182-91. [PMID: 23505317 DOI: 10.1194/jlr.R034801] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
425 Fernández-Hernando C, Ramírez CM, Goedeke L, Suárez Y. MicroRNAs in metabolic disease. Arterioscler Thromb Vasc Biol 2013;33:178-85. [PMID: 23325474 DOI: 10.1161/ATVBAHA.112.300144] [Cited by in Crossref: 179] [Cited by in F6Publishing: 182] [Article Influence: 17.9] [Reference Citation Analysis]
426 Murakami Y, Tamori A, Itami S, Tanahashi T, Toyoda H, Tanaka M, Wu W, Brojigin N, Kaneoka Y, Maeda A. The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis. BMC Cancer. 2013;13:99. [PMID: 23496901 DOI: 10.1186/1471-2407-13-99] [Cited by in Crossref: 52] [Cited by in F6Publishing: 60] [Article Influence: 5.2] [Reference Citation Analysis]
427 Li J, Ghazwani M, Zhang Y, Lu J, Li J, Fan J, Gandhi CR, Li S. miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression. J Hepatol 2013;58:522-8. [PMID: 23178710 DOI: 10.1016/j.jhep.2012.11.011] [Cited by in Crossref: 137] [Cited by in F6Publishing: 141] [Article Influence: 13.7] [Reference Citation Analysis]
428 Li J, Ghazwani M, Zhang Y, Lu J, Li J, Fan J, Gandhi CR, Li S. miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression. J Hepatol 2013;58:522-8. [PMID: 23178710 DOI: 10.1016/j.jhep.2012.11.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
429 Ranjha R, Paul J. Micro-RNAs in inflammatory diseases and as a link between inflammation and cancer. Inflamm Res. 2013;62:343-355. [PMID: 23417288 DOI: 10.1007/s00011-013-0600-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
430 Trebicka J, Anadol E, Elfimova N, Strack I, Roggendorf M, Viazov S, Wedemeyer I, Drebber U, Rockstroh J, Sauerbruch T, Dienes HP, Odenthal M. Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis. J Hepatol 2013;58:234-9. [PMID: 23085648 DOI: 10.1016/j.jhep.2012.10.015] [Cited by in Crossref: 132] [Cited by in F6Publishing: 135] [Article Influence: 13.2] [Reference Citation Analysis]
431 Fernández-Hernando C, Baldán A. MicroRNAs and Cardiovascular Disease. Curr Genet Med Rep 2013;1:30-8. [PMID: 24563824 DOI: 10.1007/s40142-013-0008-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
432 Hsu SH, Ghoshal K. MicroRNAs in Liver Health and Disease. Curr Pathobiol Rep 2013;1:53-62. [PMID: 23565350 DOI: 10.1007/s40139-012-0005-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
433 Chau BN, Esau CC, Mackenna DA, Neben S, Gibson NW. Therapeutic modulation of microRNAs. Drug Discovery Today: Therapeutic Strategies 2013;10:e127-e132. [DOI: 10.1016/j.ddstr.2013.12.002] [Reference Citation Analysis]
434 Fujii YR. RNA Wave for the HIV Therapy: Foods, Stem Cells and the RNA Information Gene. WJA 2013;03:131-146. [DOI: 10.4236/wja.2013.32018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
435 Ishida M, Selaru FM. miRNA-Based Therapeutic Strategies. Curr Anesthesiol Rep 2013;1:63-70. [PMID: 23524956 DOI: 10.1007/s40139-012-0004-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 38] [Article Influence: 1.7] [Reference Citation Analysis]
436 Norata GD, Sala F, Catapano AL, Fernández-Hernando C. MicroRNAs and lipoproteins: a connection beyond atherosclerosis? Atherosclerosis 2013;227:209-15. [PMID: 23260873 DOI: 10.1016/j.atherosclerosis.2012.11.019] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
437 Murakami Y, Toyoda H, Tanahashi T, Tanaka J, Kumada T, Yoshioka Y, Kosaka N, Ochiya T, Taguchi YH. Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease. PLoS One. 2012;7:e48366. [PMID: 23152743 DOI: 10.1371/journal.pone.0048366] [Cited by in Crossref: 120] [Cited by in F6Publishing: 127] [Article Influence: 10.9] [Reference Citation Analysis]
438 Gupta A, Swaminathan G, Martin-Garcia J, Navas-Martin S. MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy. Viruses 2012;4:2485-513. [PMID: 23202492 DOI: 10.3390/v4112485] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
439 Pan Q, van der Laan LJ. New targets for treatment against HCV infection. Best Pract Res Clin Gastroenterol 2012;26:505-15. [PMID: 23199508 DOI: 10.1016/j.bpg.2012.10.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
440 Wen J, Friedman JR. miR-122 regulates hepatic lipid metabolism and tumor suppression. J Clin Invest 2012;122:2773-6. [PMID: 22820284 DOI: 10.1172/JCI63966] [Cited by in Crossref: 83] [Cited by in F6Publishing: 87] [Article Influence: 7.5] [Reference Citation Analysis]
441 Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4:199-227. [PMID: 18817506 DOI: 10.1146/annurev.pathol.4.110807.092222] [Cited by in Crossref: 861] [Cited by in F6Publishing: 940] [Article Influence: 61.5] [Reference Citation Analysis]
442 Yan R, Tian H, Du Z. Quercetin protects PC-12 cells against hypoxia injury by down-regulation of miR-122. Iran J Basic Med Sci 2019;22:391-8. [PMID: 31168343 DOI: 10.22038/ijbms.2019.30224.7287] [Cited by in F6Publishing: 2] [Reference Citation Analysis]